CASEID,PRIMARYID,CASEVERSION,I_F_CODE,EVENT_DT,MFR_DT,INIT_FDA_DT,FDA_DT,REPT_COD,AUTH_NUM,MFR_NUM,MFR_SNDR,LIT_REF,AGE,AGE_COD,AGE_GRP,SEX,E_SUB,WT,WT_COD,REPT_DT,TO_MFR,OCCP_COD,REPORTER_COUNTRY,OCCR_COUNTRY,DRUGNAME,PT,PRIMARYID_OUTC,OUTC_COD,PRIMARYID_RPSR,RPSR_COD,PRIMARYID_THER,DSG_DRUG_SEQ,START_DT,END_DT,DUR,DUR_COD,PRIMARYID_INDI,INDI_DRUG_SEQ,INDI_PT
10251620,102516202,2,F,,20210220,20140623,20210225,PER,,US-009507513-1406USA010538,MERCK,,38,YR,,F,Y,,,20210225,,CN,US,US,EFAVIRENZ (+) EMTRICITABINE (+) TENOFOVIR DISOPROXIL FUMARATE,Pregnancy,,,,,,,,,,,102516202,1,Product used for unknown indication
11739295,117392954,4,F,,20201231,20151113,20210107,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-18707307,BRISTOL MYERS SQUIBB,SUSMAN ED. EFAVIRENZ TIED TO NEUROLOGICAL BIRTH DEFECTS. CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS. 2013,,,N,,Y,,,20210107,,HP,FR,FR,SUSTIVA,Congenital central nervous system anomaly;Foetal exposure during pregnancy,117392954,CA,,,,,,,,,117392954,1,Product used for unknown indication
11991033,1199103316,16,F,,20210308,20160202,20210313,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004939,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210313,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,1199103316,OT,,,,,,,,,1199103316,1,HIV infection
13906408,1390640813,13,F,,20210318,20170825,20210326,EXP,,CA-009507513-0809CAN00001,MERCK,,54,YR,,M,Y,,,20210326,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,1390640813,OT,,,1390640813,1,20070620,,,,1390640813,1,HIV infection
15362898,153628983,3,F,,20210202,20180907,20210208,PER,,ID-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-081902,BRISTOL MYERS SQUIBB,"MOKOAGOW I, YUWAAFII M. GRAVES DISEASE AS MANIFESTATION OF IMMUNE RECONSTITUTION SYNDROME IN A PREGNANT PATIENT WITH HIV/AIDS RECEIVING ANTIRETROVIRAL THERAPY. ENDOCRINE PRACTICE. 2018?24(SUPPL 1):270?1",36,YR,,F,Y,,,20210208,,MD,ID,ID,EFAVIRENZ.,Basedow's disease;Immune reconstitution inflammatory syndrome;Intentional product use issue;Maternal exposure during pregnancy;Normal newborn,153628983,OT,,,,,,,,,153628983,1,HIV infection
15615270,156152707,7,F,,20210118,20181114,20210129,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-103626,BRISTOL MYERS SQUIBB,"RAPOSO AF, ANTUNES AP, STRECHT T, ALVES SC, OLIVEIRA C, GUIMARAES M ET AL. PHARMACOLOGICAL COMPLEXITY IN HIV?INFECTED PATIENTS. MEDICINA INTERNA. 2017?23:1",49,YR,,M,Y,,,20210129,,HP,PT,PT,EFAVIRENZ.,Acute kidney injury;Hepatotoxicity;Tubulointerstitial nephritis,156152707,OT,,,,,,,,,156152707,1,HIV infection
15624537,156245375,5,F,,20201228,20181116,20210103,EXP,,PT-AUROBINDO-AUR-APL-2018-055802,AUROBINDO,,49,YR,,M,Y,,,20210104,,HP,PT,PT,Efavirenz Film Coated Tablets,Acute kidney injury;Hepatotoxicity;Tubulointerstitial nephritis,156245375,OT,,,,,,,,,156245375,1,HIV infection
15626751,1562675113,13,F,,20210312,20181116,20210316,EXP,,CA-ABBVIE-18S-028-2552613-00,ABBVIE,,54,YR,,M,Y,,,20210316,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,1562675113,HO,,,,,,,,,1562675113,1,HIV infection
15652146,156521463,3,F,20161005,20201228,20181123,20210105,EXP,,US-GILEAD-2018-0376080,GILEAD,,47,YR,A,M,Y,94.33,KG,20210105,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;Pain;Renal failure,156521463,HO,,,156521463,1,2006,2016,,,156521463,1,HIV infection
16020890,1602089013,13,F,,20210312,20190301,20210324,EXP,,CA-AUROBINDO-AUR-APL-2019-010743,AUROBINDO,,54,YR,,M,Y,,,20210324,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,1602089013,DE,,,,,,,,,1602089013,1,HIV infection
16080755,160807555,5,F,,20210209,20190316,20210217,EXP,,CA-AUROBINDO-AUR-APL-2019-013379,AUROBINDO,,44,YR,,M,Y,,,20210217,,HP,CA,CA,SUSTIVA,Anxiety,160807555,OT,,,,,,,,,160807555,1,Psychotic disorder
16081152,160811524,4,F,,20210312,20190316,20210324,EXP,,CA-AUROBINDO-AUR-APL-2019-013775,AUROBINDO,,,,,M,Y,,,20210324,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,160811524,OT,,,,,,,,,160811524,1,Product used for unknown indication
16081155,160811556,6,F,,20210312,20190316,20210324,EXP,,CA-AUROBINDO-AUR-APL-2019-013363,AUROBINDO,,54,YR,,M,Y,,,20210324,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,160811556,HO,,,,,,,,,160811556,1,HIV infection
16206633,162066333,3,F,,20210310,20190417,20210320,EXP,,CA-AUROBINDO-AUR-APL-2019-019815,AUROBINDO,,,,,M,Y,,,20210320,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction,162066333,OT,,,,,,,,,162066333,1,Product used for unknown indication
16214079,162140794,4,F,2004,20210111,20190418,20210125,PER,,US-GILEAD-2019-0402864,GILEAD,,47,YR,A,M,Y,86.62,KG,20210125,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Decreased activity;Depression;Economic problem;Emotional distress;Inflammation;Insomnia;Pain,162140794,OT,,,162140794,1,200401,200612,,,162140794,1,HIV infection
16266182,162661825,5,F,2006,20201002,20190502,20210222,EXP,,US-GILEAD-2019-0405370,GILEAD,,55,YR,A,M,Y,90.7,KG,20210222,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Economic problem;Emotional distress;Lipohypertrophy;Loss of personal independence in daily activities;Osteonecrosis;Pain in extremity;Renal failure,162661825,OT,,,162661825,1,200602,200802,,,162661825,1,HIV infection
16306821,163068212,2,F,200608,20210210,20190513,20210218,EXP,,US-ASTRAZENECA-2019SE64123,ASTRAZENECA,,504,MON,,F,Y,52.2,KG,20210218,,,US,US,SUSTIVA,Chronic kidney disease,163068212,OT,,,163068212,1,2001,201105,,,163068212,1,Gastrooesophageal reflux disease
16312898,163128982,2,F,,20210212,20190515,20210223,EXP,,CA-APOTEX-2019AP014514,APOTEX,,,,I,,Y,,,20210223,,CN,CA,CA,EFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE;MYLAN EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Atrial septal defect;Foetal exposure during pregnancy;Ventricular septal defect,163128982,CA,,,,,,,,,163128982,1,Product used for unknown indication
16321491,163214913,3,F,20090501,20210210,20190516,20210223,PER,,US-GILEAD-2019-0407756,GILEAD,,40,YR,A,M,Y,98.41,KG,20210223,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone pain;Chronic kidney disease;Drug resistance;Economic problem;Emotional distress;Fanconi syndrome acquired;Gait disturbance;Pain;Renal impairment,163214913,OT,,,163214913,1,200110,200609,,,163214913,1,HIV infection
16325136,163251362,2,F,,20210126,20190517,20210205,EXP,,CA-APOTEX-2019AP013869,APOTEX,,,,,,Y,,,20210205,,CN,CA,CA,EFAVIRENZ;EMTRICITABINE;TENOFOVIR DISOPROXIL MALEATE,Atrial septal defect;Foetal exposure during pregnancy;Ventricular septal defect,163251362,CA,,,,,,,,,163251362,1,HIV infection
16325325,163253255,5,F,2003,20201201,20190517,20210120,EXP,,US-GILEAD-2019-0407769,GILEAD,,,,A,M,Y,70.3,KG,20210120,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Back pain;Bone density decreased;Bone pain;Chronic kidney disease;Depression;Economic problem;Emotional distress;Hypercreatininaemia;Osteoarthritis;Osteonecrosis;Pain;Pain in extremity;Renal failure;Renal pain,163253255,OT,,,163253255,1,200305,200409,,,163253255,1,HIV infection
16326384,163263843,3,F,201010,20210128,20190517,20210210,EXP,,US-GILEAD-2019-0407830,GILEAD,,53,YR,A,M,Y,82.99,KG,20210210,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Chronic kidney disease;Economic problem;Emotional distress;Fall;Fibula fracture;Hand fracture;Lower limb fracture;Muscular weakness;Osteopenia;Pain;Proteinuria;Tibia fracture,163263843,OT,,,163263843,1,20100419,20150713,,,163263843,1,HIV infection
16334713,163347135,5,F,2008,20201228,20190520,20210105,EXP,,US-GILEAD-2019-0408522,GILEAD,,59,YR,A,M,Y,75.7,KG,20210105,,CN,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Bone density decreased;Depression;Economic problem;Emotional distress;Fall;Femoral neck fracture;Gait disturbance;Osteomalacia;Osteopenia;Osteoporosis;Osteoporotic fracture;Pain;Tooth loss,163347135,DS,,,163347135,1,200402,201303,,,163347135,1,HIV infection
16340986,163409862,2,F,20171007,20210122,20190522,20210204,EXP,,US-GILEAD-2019-0408031,GILEAD,,48,YR,A,F,Y,95.24,KG,20210204,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Cough;Economic problem;Emotional distress;General physical health deterioration;Impaired work ability;Lower limb fracture;Osteopenia;Osteoporosis;Pain;Quality of life decreased;Rib fracture;Walking aid user,163409862,OT,,,163409862,1,2004,2012,,,163409862,1,HIV infection
16622566,166225664,4,F,,20210105,20190723,20210118,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-069006,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210118,,CN,CA,CA,SUSTIVA,Blood lactic acid increased;Diplopia;Dysphagia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia,166225664,OT,,,,,,,,,166225664,1,HIV infection
16728623,167286232,2,F,,20210210,20190822,20210222,EXP,,CA-AUROBINDO-AUR-APL-2019-054269,AUROBINDO,,,,,M,Y,,,20210222,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction,167286232,OT,,,,,,,,,167286232,1,Product used for unknown indication
16761858,167618583,3,F,201210,20210112,20190830,20210126,EXP,,US-GILEAD-2019-0425666,GILEAD,,48,YR,A,M,Y,121.09,KG,20210126,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;Multiple injuries;Pain;Pain in extremity;Renal failure;Tooth fracture;Tooth loss,167618583,OT,,,167618583,1,2002,201202,,,167618583,1,HIV infection
16765537,167655376,6,F,20131026,20210310,20190903,20210324,EXP,,US-GILEAD-2019-0425749,GILEAD,,51,YR,A,M,Y,74.39,KG,20210324,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Economic problem;Emotional distress;Hand fracture;Pain;Tooth loss,167655376,OT,,,167655376,1,2014,2019,,,167655376,1,HIV infection
16774553,167745534,4,F,2018,20210104,20190905,20210111,EXP,,US-GILEAD-2019-0425688,GILEAD,,53,YR,A,M,Y,73.47,KG,20210111,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Economic problem;Emotional distress;Multiple injuries;Pain;Panic attack,167745534,OT,,,167745534,1,2011,201803,,,167745534,1,HIV infection
16779164,167791646,6,F,201404,20210319,20190906,20210323,EXP,,US-GILEAD-2019-0426574,GILEAD,,47,YR,A,M,Y,108,KG,20210323,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Multiple fractures;Osteonecrosis;Pain;Renal failure,167791646,OT,,,167791646,1,200301,201404,,,167791646,1,HIV infection
16789078,1678907810,10,F,20150518,20210323,20190910,20210329,EXP,,US-GILEAD-2019-0426612,GILEAD,,48,YR,A,M,Y,123.36,KG,20210329,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Osteopenia;Osteoporosis;Pain;Renal failure,1678907810,OT,,,1678907810,1,2012,2019,,,1678907810,1,HIV infection
16826060,168260603,3,F,,20210309,20190919,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-059880,AUROBINDO,,44,YR,,M,Y,,,20210317,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,168260603,OT,,,,,,,,,168260603,1,Psychotic disorder
16837827,168378274,4,F,201607,20210113,20190923,20210127,EXP,,US-GILEAD-2019-0429625,GILEAD,,64,YR,,M,Y,,,20210127,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;Injury;Pain;Renal failure,168378274,DE,,,168378274,1,20130416,201507,,,168378274,1,HIV infection
16838529,168385293,3,F,20130422,20210303,20190923,20210311,EXP,,US-GILEAD-2019-0429261,GILEAD,,54,YR,A,F,Y,142,KG,20210311,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Decreased activity;Depression;Economic problem;Emotional distress;Immobile;Loss of personal independence in daily activities;Pain;Quality of life decreased;Renal cyst;Renal failure;Renal pain,168385293,OT,,,168385293,1,2010,20150321,,,168385293,1,HIV infection
16839622,168396224,4,F,2012,20210225,20190923,20210309,EXP,,US-GILEAD-2019-0429613,GILEAD,,30,YR,A,M,Y,82.09,KG,20210309,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Decreased activity;Drug hypersensitivity;Drug resistance;Economic problem;Emotional distress;Insomnia;Jaundice;Loss of personal independence in daily activities;Pain;Pollakiuria;Quality of life decreased;Renal failure;T-lymphocyte count abnormal,168396224,OT,,,168396224,1,2003,2009,,,168396224,1,HIV infection
16839623,168396233,3,F,2006,20210305,20190923,20210311,EXP,,US-GILEAD-2019-0429680,GILEAD,,59,YR,A,M,Y,106.12,KG,20210311,,CN,US,US,SUSTIVA,Abdominal pain upper;Anhedonia;Anxiety;Cachexia;Diarrhoea;Economic problem;Emotional distress;Femur fracture;Flatulence;Joint injury;Limb injury;Osteopenia;Osteoporosis;Pain,168396233,OT,,,168396233,1,2012,201707,,,168396233,1,HIV infection
16850098,168500983,3,F,2005,20201224,20190925,20210104,EXP,,US-GILEAD-2019-0429508,GILEAD,,41,YR,A,M,Y,77.1,KG,20210104,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthritis;Bone density decreased;Bone loss;Bone pain;Carpal tunnel syndrome;Decreased activity;Depression;Economic problem;Emotional distress;Grip strength decreased;Loss of personal independence in daily activities;Nephropathy;Osteopenia;Osteoporosis;Pain;Plantar fasciitis;Quality of life decreased;Tendonitis,168500983,OT,,,168500983,1,2001,2008,,,168500983,1,HIV infection
16853159,168531593,3,F,200408,20210120,20190925,20210202,EXP,,US-GILEAD-2019-0429655,GILEAD,,66,YR,E,M,Y,58.96,KG,20210202,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Economic problem;Emotional distress;Fear;Foot fracture;Loss of personal independence in daily activities;Lower limb fracture;Osteopenia;Osteoporosis;Pain;Quality of life decreased;Renal impairment;Rib fracture;Upper limb fracture,168531593,OT,,,168531593,1,20041115,20080926,,,168531593,1,HIV infection
16854016,168540163,3,F,2011,20210305,20190926,20210311,EXP,,US-GILEAD-2019-0429760,GILEAD,,,,A,M,Y,,,20210311,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Economic problem;Emotional distress;Pain;Renal failure,168540163,HO,,,168540163,1,2007,20150916,,,168540163,1,HIV infection
16854037,168540374,4,F,201412,20210125,20190926,20210205,EXP,,US-GILEAD-2019-0429745,GILEAD,,63,YR,E,M,Y,214,KG,20210205,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Fatigue;Loss of personal independence in daily activities;Pain;Renal failure;Vitamin D deficiency,168540374,OT,,,168540374,1,2012,2018,,,168540374,1,HIV infection
16856450,168564504,4,F,201106,20200708,20190926,20210209,PER,,US-GILEAD-2019-0429605,GILEAD,,26,YR,A,M,Y,79.37,KG,20210209,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Depression;Drug ineffective;Economic problem;Emotional distress;End stage renal disease;Fatigue;Hyperparathyroidism;Hyperthyroidism;Hyperuricaemia;Impaired work ability;Nephropathy;Pain;Proteinuria;Renal disorder;Renal failure,168564504,HO,,,168564504,1,2010,2017,,,168564504,1,HIV infection
16856454,168564542,2,F,20120923,20210208,20190926,20210224,EXP,,US-GILEAD-2019-0429624,GILEAD,,23,YR,A,M,Y,72.56,KG,20210224,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Death;Decreased activity;Emotional distress;Fear;Impaired work ability;Loss of personal independence in daily activities;Pain;Quality of life decreased;Renal failure;Renal injury;Skeletal injury,168564542,HO,,,168564542,1,2008,2013,,,168564542,1,HIV infection
16858242,168582423,3,F,20150906,20201229,20190926,20210108,EXP,,US-GILEAD-2019-0429395,GILEAD,,54,YR,A,M,Y,54.42,KG,20210108,,CN,US,US,SUSTIVA,Acute kidney injury;Amnesia;Anaemia;Anhedonia;Anxiety;Asthenia;Chronic kidney disease;Death;Decreased activity;Discomfort;Disturbance in attention;Economic problem;Emotional distress;Gait disturbance;Loss of personal independence in daily activities;Nephropathy;Pain;Quality of life decreased,168582423,OT,,,168582423,1,2006,20151103,,,168582423,1,HIV infection
16858956,168589563,3,F,20090630,20210128,20190926,20210209,EXP,,US-GILEAD-2019-0429204,GILEAD,,45,YR,A,F,Y,47.62,KG,20210209,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Decreased activity;Depression;Economic problem;Emotional distress;Fatigue;Loss of personal independence in daily activities;Pain;Quality of life decreased;Renal failure;Renal pain,168589563,HO,,,168589563,1,2004,2015,,,168589563,1,HIV infection
16861811,168618113,3,F,201011,20210112,20190927,20210125,EXP,,US-GILEAD-2019-0429413,GILEAD,,55,YR,A,M,Y,45.35,KG,20210125,,CN,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Decreased activity;Economic problem;Emotional distress;Fatigue;Loss of personal independence in daily activities;Pain;Quality of life decreased,168618113,OT,,,168618113,1,200910,201011,,,168618113,1,HIV infection
17034605,170346056,6,F,,20210309,20191115,20210319,EXP,,CA-009507513-1911CAN004586,MERCK,,52,YR,,M,Y,,,20210319,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Diplopia;Extraocular muscle paresis;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia;Progressive external ophthalmoplegia,170346056,OT,,,,,,,,,170346056,1,HIV infection
17198087,171980874,4,F,,20210304,20191225,20210305,EXP,,CA-ROCHE-2500389,ROCHE,,54,YR,,M,Y,,,20210305,,HP,CA,CA,EFAVIRENZ.,Depression;Drug interaction;Loss of personal independence in daily activities,171980874,OT,,,,,,,,,171980874,1,Bipolar disorder
17244297,172442977,7,F,2006,20210105,20200107,20210115,EXP,,US-GILEAD-2019-0444758,GILEAD,,54,YR,A,M,Y,81.63,KG,20210115,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density abnormal;Bone density decreased;Depression;Economic problem;Emotional distress;Fracture;Hypersensitivity;Osteopenia;Osteoporosis;Pain;Renal failure;Tooth loss;Upper limb fracture,172442977,OT,,,172442977,1,200604,201701,,,172442977,1,HIV infection
17244308,172443084,4,F,2014,20210323,20200107,20210329,EXP,,US-GILEAD-2019-0444842,GILEAD,,52,YR,A,F,Y,70.31,KG,20210329,,CN,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Depression;Economic problem;Emotional distress;Multiple fractures;Osteopenia;Osteoporosis;Pain,172443084,OT,,,172443084,1,20121011,20150409,,,172443084,1,HIV infection
17347351,173473514,4,F,2009,20210208,20200130,20210222,EXP,,US-GILEAD-2020-0448787,GILEAD,,34,YR,A,M,Y,65.76,KG,20210222,,CN,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Pain,173473514,OT,,,173473514,1,201407,2016,,,173473514,1,HIV infection
17349167,173491673,3,F,20101014,20210315,20200130,20210330,EXP,,US-GILEAD-2020-0448797,GILEAD,,36,YR,A,M,Y,79.37,KG,20210330,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Pain;Renal failure,173491673,OT,,,173491673,1,2001,20170802,,,173491673,1,HIV infection
17353625,173536254,4,F,201206,20210122,20200131,20210319,EXP,,US-GILEAD-2020-0448749,GILEAD,,46,YR,A,M,Y,52.15,KG,20210319,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine decreased;Bone density decreased;Chronic kidney disease;Clavicle fracture;Economic problem;Emotional distress;Osteoporosis;Pain,173536254,OT,,,173536254,2,2010,201005,,,173536254,1,HIV infection
17354354,173543544,4,F,201306,20210103,20200131,20210111,EXP,,US-GILEAD-2020-0448785,GILEAD,,62,YR,A,M,Y,67,KG,20210111,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Economic problem;Emotional distress;End stage renal disease;Osteopenia;Pain;Renal disorder;Renal failure,173543544,OT,,,173543544,1,2013,20100323,,,173543544,1,HIV infection
17441515,174415154,4,F,20110601,20210315,20200220,20210316,EXP,,US-GILEAD-2020-0451447,GILEAD,,43,YR,A,M,Y,126.08,KG,20210316,,LW,US,US,SUSTIVA,Acute kidney injury;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Fracture;Osteoporosis;Pain;Renal failure;Tooth loss,174415154,OT,,,174415154,1,2006,201912,,,174415154,1,HIV infection
17484391,174843918,8,F,200909,20210224,20200302,20210305,EXP,,US-GILEAD-2020-0452915,GILEAD,,51,YR,A,M,Y,88.44,KG,20210305,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Cerebral haemorrhage;Condition aggravated;Economic problem;Emotional distress;Fear of falling;Loss of personal independence in daily activities;Nephrolithiasis;Osteopenia;Osteoporosis;Pain;Physical disability;Renal impairment;Tooth fracture;Tooth loss,174843918,OT,,,174843918,1,20090225,20100809,,,174843918,1,HIV infection
17574109,175741095,5,F,2017,20201203,20200323,20210112,EXP,,US-GILEAD-2020-0456091,GILEAD,,,,A,M,Y,90.7,KG,20210112,,LW,US,US,EFAVIRENZ.;SUSTIVA,Anhedonia;Anxiety;Depression;Economic problem;Emotional distress;End stage renal disease;Pain;Renal failure,175741095,OT,,,175741095,1,2006,20180109,,,175741095,1,HIV infection
17574821,175748212,2,F,2006,20210119,20200324,20210201,EXP,,US-GILEAD-2020-0455937,GILEAD,,,,A,M,Y,63.5,KG,20210201,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Economic problem;Emotional distress;End stage renal disease;Pain;Pneumonia;Renal failure,175748212,HO,,,175748212,1,2001,2004,,,175748212,1,HIV infection
17577668,175776683,3,F,1998,20210217,20200324,20210301,EXP,,US-GILEAD-2020-0456010,GILEAD,,,,A,M,Y,83.9,KG,20210301,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Depression;Economic problem;Emotional distress;Hand fracture;Osteopenia;Osteoporosis;Pain,175776683,OT,,,175776683,1,2001,2001,,,175776683,1,HIV infection
17677484,176774843,3,F,2006,20210108,20200416,20210122,PER,,US-GILEAD-2020-0459254,GILEAD,,47,YR,A,M,Y,87.9,KG,20210122,,CN,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Drug ineffective;Economic problem;Emotional distress;Osteoporosis;Pain,176774843,HO,,,176774843,1,201906,201911,,,176774843,1,HIV infection
17679133,176791333,3,F,2011,20210129,20200417,20210211,PER,,US-GILEAD-2020-0459235,GILEAD,,48,YR,A,M,Y,81.63,KG,20210211,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Economic problem;Emotional distress;Osteopenia;Pain;Proteinuria;Renal failure,176791333,OT,,,176791333,1,200601,201003,,,176791333,1,HIV infection
17679533,176795334,4,F,20120531,20210212,20200417,20210225,EXP,,US-GILEAD-2020-0459258,GILEAD,,56,YR,A,M,Y,84.35,KG,20210225,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone pain;Carpal tunnel syndrome;Depression;Dyspnoea;Economic problem;Emotional distress;Gastrointestinal disorder;Impaired work ability;Injury;Insomnia;Myalgia;Osteopenia;Pain;Panic attack;Sitting disability;Sleep apnoea syndrome,176795334,OT,,,176795334,1,20030811,2005,,,176795334,1,HIV infection
17681702,176817023,3,F,2013,20210224,20200417,20210305,EXP,,US-GILEAD-2020-0459245,GILEAD,,,,A,M,Y,68.03,KG,20210305,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Economic problem;Emotional distress;Osteonecrosis;Osteopenia;Osteoporosis;Pain;Proteinuria,176817023,OT,,,176817023,1,201008,201602,,,176817023,1,HIV infection
17703788,177037884,4,F,201804,20210106,20200424,20210118,EXP,,US-GILEAD-2020-0460165,GILEAD,,54,YR,A,M,Y,78.01,KG,20210118,,LW,US,US,SUSTIVA,Anxiety;Arthralgia;Blood creatinine increased;Bone density decreased;Bone loss;Chronic kidney disease;Depression;Dizziness;Economic problem;Emotional distress;Fracture;Nausea;Osteomalacia;Osteonecrosis;Osteoporosis;Pain;Pathological fracture,177037884,OT,,,177037884,1,2005,20190404,,,177037884,1,HIV infection
17736679,177366793,3,F,2017,20210122,20200501,20210204,EXP,,US-GILEAD-2020-0463103,GILEAD,,61,YR,A,M,Y,72.56,KG,20210204,,CN,US,US,SUSTIVA,Acute kidney injury;Anaemia;Chronic kidney disease;End stage renal disease;Hepatitis C;Hyperkalaemia;Hypertension;Renal failure,177366793,OT,,,177366793,1,2004,2016,,,177366793,1,HIV infection
17743771,177437713,3,F,,20210216,20200505,20210226,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2020GSK075602,VIIV,,54,YR,,M,Y,,,20210226,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction;Loss of personal independence in daily activities,177437713,OT,,,,,,,,,177437713,1,Bipolar disorder
17743782,177437823,3,F,,20210216,20200505,20210226,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK075602,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210226,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction;Loss of personal independence in daily activities,177437823,OT,,,,,,,,,177437823,1,Bipolar disorder
17772651,177726513,3,F,201810,20201211,20200512,20210125,EXP,,US-GILEAD-2020-0466109,GILEAD,,56,YR,A,F,Y,,,20210125,,LW,US,US,SUSTIVA,Ankle fracture;Bone density decreased;Bone loss;Multiple fractures;Osteonecrosis;Osteoporosis;Renal injury;Skeletal injury,177726513,OT,,,177726513,1,2004,,,,177726513,1,HIV infection
17904644,179046447,7,F,20020111,20210204,20200617,20210211,EXP,,US-GILEAD-2020-0471554,GILEAD,,65,YR,E,M,Y,88.44,KG,20210211,,LW,US,US,SUSTIVA,Blood creatinine increased;Chronic kidney disease;Drug ineffective;Fanconi syndrome acquired;Lumbar vertebral fracture;Multiple fractures;Nephropathy;Radiculopathy;Renal failure;Viral load increased,179046447,OT,,,179046447,1,20020111,20050525,,,179046447,1,HIV infection
17924753,179247532,2,F,,20210105,20200622,20210108,EXP,,CA-ROCHE-2622329,ROCHE,,,,,M,Y,,,20210108,,HP,CA,CA,SUSTIVA,Abnormal dreams;Drug interaction;Erectile dysfunction;Liver injury;Nail disorder;Renal impairment;Skin ulcer;Thirst;Visual acuity reduced,179247532,OT,,,,,,,,,179247532,1,Product used for unknown indication
17985085,179850852,2,F,,20210125,20200706,20210201,EXP,,GB-VIIV HEALTHCARE LIMITED-GB2020EME116192,VIIV,,,,,M,Y,,,20210201,,CN,GB,GB,EFAVIRENZ.,Feeling abnormal;Hospitalisation;Life expectancy shortened;Lung cancer metastatic;Lung neoplasm malignant;Malaise;Metastases to central nervous system,179850852,OT,,,,,,,,,179850852,1,Product used for unknown indication
17985108,179851082,2,F,,20210125,20200706,20210201,EXP,,GB-GLAXOSMITHKLINE-GB2020EME116192,GLAXOSMITHKLINE,,,,,M,Y,,,20210201,,CN,GB,GB,EFAVIRENZ.,Feeling abnormal;Hospitalisation;Life expectancy shortened;Lung cancer metastatic;Lung neoplasm malignant;Malaise;Metastases to central nervous system,179851082,OT,,,,,,,,,179851082,1,Product used for unknown indication
18022832,180228323,3,F,2020,20200824,20200715,20210101,PER,,DE-HORMOSAN PHARMA GMBH-2020-02278,LUPIN,,44,YR,,M,Y,,,20210101,,CN,DE,DE,EFAVIRENZ.,Arthralgia;Back pain;Faeces soft;Fatigue;Muscle disorder;Myalgia;Pain in extremity;Rash,,,,,,,,,,,180228323,1,HIV infection
18057020,180570202,2,F,20090212,20210210,20200722,20210224,EXP,,US-GILEAD-2020-0484454,GILEAD,,33,YR,A,M,Y,88.44,KG,20210224,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Chronic kidney disease;Decreased activity;Emotional distress;Fatigue;Loss of personal independence in daily activities;Pain;Quality of life decreased;Renal disorder;Renal failure,180570202,HO,,,180570202,1,20040120,20050519,,,180570202,1,HIV infection
18073688,180736882,2,F,,20210216,20200727,20210226,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2020GSK143017,VIIV,,54,YR,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,180736882,OT,,,,,,,,,180736882,1,Bipolar disorder
18073693,180736932,2,F,,20210216,20200727,20210226,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK143017,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,180736932,OT,,,,,,,,,180736932,1,Bipolar disorder
18079728,180797282,2,F,,20210216,20200728,20210223,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2020GSK143033,VIIV,,,,,M,Y,,,20210223,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,180797282,DE,,,,,,,,,180797282,1,Product used for unknown indication
18079730,180797302,2,F,,20210216,20200728,20210223,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK143033,GLAXOSMITHKLINE,,,,,M,Y,,,20210223,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,180797302,DE,,,,,,,,,180797302,1,Product used for unknown indication
18087033,180870332,2,F,,20210118,20200729,20210202,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2020GSK142975,VIIV,,54,YR,,M,Y,,,20210202,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,180870332,OT,,,,,,,,,180870332,1,Product used for unknown indication
18087039,180870392,2,F,,20210118,20200729,20210202,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK142975,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210202,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,180870392,OT,,,,,,,,,180870392,1,Product used for unknown indication
18102908,181029083,3,F,2017,20210119,20200803,20210201,PER,,US-GILEAD-2020-0486603,GILEAD,,,,A,M,Y,108,KG,20210201,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Emotional distress;Nephrolithiasis;Pain;Proteinuria;Renal impairment;Stress,181029083,OT,,,181029083,1,2004,2018,,,181029083,1,HIV infection
18105661,181056613,3,F,201601,20210209,20200804,20210223,EXP,,US-GILEAD-2020-0486474,GILEAD,,51,YR,A,M,Y,131.07,KG,20210223,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Dysstasia;Emotional distress;Osteoarthritis;Pain,181056613,OT,,,181056613,1,2004,201703,,,181056613,1,HIV infection
18106071,181060713,3,F,2015,20210119,20200804,20210204,PER,,US-GILEAD-2020-0486758,GILEAD,,,,A,M,Y,94.33,KG,20210204,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Bone density decreased;Bone pain;Emotional distress;Fracture;Gait disturbance;Pain;Renal failure;Rib fracture,181060713,OT,,,181060713,1,200912,201309,,,181060713,1,HIV infection
18141192,181411922,2,F,20150716,20201229,20200812,20210106,EXP,,US-GILEAD-2020-0489338,GILEAD,,63,YR,A,M,Y,76.19,KG,20210106,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Mobility decreased;Pain,181411922,OT,,,181411922,1,2008,20160613,,,181411922,1,HIV infection
18154052,181540523,3,F,20160912,20210119,20200816,20210312,PER,,US-GILEAD-2020-0489413,GILEAD,,59,YR,A,F,Y,80.3,KG,20210312,,CN,US,US,SUSTIVA,Anxiety;Bone density decreased;Emotional distress;Osteopenia;Renal impairment,,,,,181540523,1,20140415,,,,181540523,1,HIV infection
18158478,181584783,3,F,2016,20210209,20200817,20210224,EXP,,US-GILEAD-2020-0490412,GILEAD,,,,A,M,Y,104.31,KG,20210224,,LW,US,US,EFAVIRENZ.;SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Pain,181584783,OT,,,181584783,1,2012,2018,,,181584783,1,HIV infection
18166711,181667113,3,F,201207,20210325,20200819,20210330,EXP,,US-GILEAD-2020-0490497,GILEAD,,71,YR,A,M,Y,125,KG,20210330,,LW,US,US,EFAVIRENZ.,Anhedonia;Anxiety;Emotional distress;Osteopenia;Osteoporosis;Pain;Renal impairment,181667113,OT,,,181667113,1,201009,20180108,,,181667113,1,HIV infection
18168897,181688973,3,F,2005,20210217,20200818,20210301,EXP,,US-GILEAD-2020-0490418,GILEAD,,,,A,M,Y,112.47,KG,20210301,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Cervical vertebral fracture;Emotional distress;Lumbar vertebral fracture;Osteoporosis;Pain;Renal impairment,181688973,OT,,,181688973,1,2004,20190827,,,181688973,1,HIV infection
18171264,181712644,4,F,201601,20210107,20200819,20210121,EXP,,US-GILEAD-2020-0490139,GILEAD,,54,YR,A,M,Y,114.29,KG,20210121,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Depression;Emotional distress;Multiple fractures;Osteonecrosis;Osteoporosis;Pain;Tooth loss,181712644,OT,,,181712644,1,2004,2008,,,181712644,1,HIV infection
18171947,181719473,3,F,200705,20210217,20200819,20210303,EXP,,US-GILEAD-2020-0490066,GILEAD,,32,YR,A,M,Y,78.9,KG,20210303,,LW,US,US,EFAVIRENZ.;SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;Fracture;Osteoporosis;Pain,181719473,OT,,,181719473,1,20070118,200809,,,181719473,1,HIV infection
18173013,181730133,3,F,2015,20210106,20200819,20210121,PER,,US-GILEAD-2020-0489954,GILEAD,,36,YR,A,M,Y,,,20210121,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;Intervertebral disc protrusion;Osteopenia;Osteoporosis;Pain;Renal injury,181730133,OT,,,181730133,1,2010,20121016,,,181730133,1,HIV infection
18179064,181790643,3,F,20160728,20210208,20200821,20210223,EXP,,US-GILEAD-2020-0490483,GILEAD,,60,YR,A,M,Y,77.1,KG,20210223,,CN,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Drug ineffective;Emotional distress;Pain,181790643,HO,,,181790643,1,2001,201309,,,181790643,1,HIV infection
18179409,181794095,5,F,,20210221,20200821,20210308,EXP,,CA-ROCHE-2583896,ROCHE,,52,YR,,M,Y,,,20210308,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Blood lactic acid increased;Diplopia;Dysphagia;Extraocular muscle paresis;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia;Progressive external ophthalmoplegia,181794095,OT,,,,,,,,,181794095,1,HIV infection
18194619,181946193,3,F,,20210322,20200825,20210331,EXP,,CA-ASTRAZENECA-2020SF06767,ASTRAZENECA,,54,YR,,M,Y,,,20210331,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,181946193,OT,,,,,,,,,181946193,1,Bipolar disorder
18195354,181953543,3,F,2008,20200911,20200825,20210125,EXP,,US-GILEAD-2020-0490990,GILEAD,,,,A,F,Y,53.06,KG,20210125,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Foot fracture;Hip fracture;Multiple fractures;Osteoporosis;Pain,181953543,HO,,,181953543,1,2006,2016,,,181953543,1,HIV infection
18196776,181967762,2,F,2006,20210211,20200826,20210223,PER,,US-GILEAD-2020-0491925,GILEAD,,,,A,M,Y,120.64,KG,20210223,,LW,US,US,SUSTIVA,Anxiety;Blood creatinine increased;Emotional distress;Fatigue;Feeling drunk;Headache;Migraine;Mood swings;Pain;Renal impairment,,,,,181967762,1,2006,2012,,,181967762,1,HIV infection
18199815,181998153,3,F,2015,20210304,20200826,20210310,EXP,,US-GILEAD-2020-0491171,GILEAD,,50,YR,A,F,Y,79.37,KG,20210310,,CN,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Depression;Emotional distress;Fanconi syndrome acquired;Osteopenia;Pain;Renal disorder;Renal tubular dysfunction,181998153,OT,,,181998153,1,201304,201409,,,181998153,1,HIV infection
18227744,182277442,2,F,,20210216,20200903,20210303,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK176607,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210303,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,182277442,OT,,,,,,,,,182277442,1,Bipolar disorder
18227941,182279412,2,F,,20210216,20200903,20210303,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2020GSK176607,VIIV,,54,YR,,M,Y,,,20210303,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,182279412,OT,,,,,,,,,182279412,1,Bipolar disorder
18228493,182284933,3,F,20060629,20210313,20200903,20210316,EXP,,US-GILEAD-2020-0492171,GILEAD,,44,YR,A,M,Y,83.9,KG,20210316,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Fatigue;Insomnia;Liver disorder;Pain;Proteinuria;Renal impairment,182284933,OT,,,182284933,1,201109,201703,,,182284933,1,HIV infection
18242103,182421032,2,F,201712,20210122,20200908,20210205,EXP,,US-GILEAD-2020-0494027,GILEAD,,52,YR,A,M,Y,81.63,KG,20210205,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Pain,182421032,OT,,,182421032,1,2009,2012,,,182421032,1,HIV infection
18251715,182517153,3,F,20110511,20210317,20200910,20210319,PER,,US-GILEAD-2020-0494290,GILEAD,,48,YR,A,M,Y,,,20210319,,LW,US,US,SUSTIVA,Acute kidney injury;Anaemia of chronic disease;Anhedonia;Anxiety;Dyspnoea;Emotional distress;End stage renal disease;Erectile dysfunction;Focal segmental glomerulosclerosis;Hyperparathyroidism secondary;Loss of personal independence in daily activities;Pain;Proteinuria,182517153,OT,,,182517153,1,2006,20110712,,,182517153,1,HIV infection
18252769,182527692,2,F,2016,20210301,20200910,20210310,EXP,,US-GILEAD-2020-0494492,GILEAD,,67,YR,E,M,Y,63.49,KG,20210310,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Dysstasia;Emotional distress;Femur fracture;Gait disturbance;Multiple fractures;Osteoporosis;Pain;Pelvic fracture;Upper limb fracture;Wrist fracture,182527692,HO,,,182527692,1,2010,201612,,,182527692,1,HIV infection
18256570,182565702,2,F,2014,20210130,20200911,20210212,EXP,,US-GILEAD-2020-0494621,GILEAD,,,,A,M,Y,68.03,KG,20210212,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Emotional distress;Foot fracture;Fractured coccyx;Osteoporosis;Pain;Rib fracture,182565702,OT,,,182565702,1,2004,201903,,,182565702,1,HIV infection
18257450,182574502,2,F,201108,20210126,20200911,20210209,EXP,,US-GILEAD-2020-0494599,GILEAD,,33,YR,A,F,Y,147.39,KG,20210208,,LW,US,US,SUSTIVA,Emotional distress;End stage renal disease;Pain,182574502,OT,,,182574502,1,2006,2018,,,182574502,1,HIV infection
18261232,182612323,3,F,,20200831,20200914,20210112,EXP,,UG-CIPLA (EU) LIMITED-2020UG06367,CIPLA,"KIGGUNDU R, RHEIN J, MEYA DB, BOULWARE DR, BAHR NC.. UNMASKING CRYPTOCOCCAL MENINGITIS IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN PREGNANCY INDUCED BY HIV ANTIRETROVIRAL THERAPY WITH POSTPARTUM. MEDICAL MYCOLOGY CASE REPORTS. 2014?1 TO 9",,,,,Y,,,20210112,,HP,UG,UG,EFAVIRENZ.,Foetal exposure during pregnancy;Low birth weight baby;Neonatal respiratory distress;Premature baby,182612323,OT,,,,,,,,,,,
18269411,182694112,2,F,20100118,20210203,20200915,20210217,EXP,,US-GILEAD-2020-0494051,GILEAD,,39,YR,A,F,Y,80.27,KG,20210217,,LW,US,US,SUSTIVA,Acute kidney injury;Anaemia;Anhedonia;Anxiety;Depression;Emotional distress;End stage renal disease;Hyperkalaemia;Hypertension;Pain;Pneumonia;Renal failure;Renal injury;Seizure,182694112,OT,,,182694112,1,200911,20180430,,,182694112,1,HIV infection
18269696,182696963,3,F,2010,20210315,20200915,20210318,EXP,,US-GILEAD-2020-0494607,GILEAD,,,,A,M,Y,70.3,KG,20210318,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Pain;Renal failure,182696963,OT,,,182696963,1,2001,2006,,,182696963,1,HIV infection
18286798,182867983,3,F,2018,20210210,20200921,20210224,EXP,,US-GILEAD-2020-0494043,GILEAD,,,,A,M,Y,84.3,KG,20210224,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Bone disorder;Emotional distress;Osteopenia;Osteoporosis;Pain,182867983,OT,,,182867983,1,2003,2007,,,182867983,1,HIV infection
18299725,182997252,2,F,200909,20200915,20200923,20210112,EXP,,ZA-CIPLA LTD.-2020ZA06612,CIPLA,,,,,,Y,,,20210112,,PH,ZA,ZA,EFAVIRENZ.,Diarrhoea;Drug interaction;Drug resistance;Insomnia;Treatment noncompliance;Virologic failure,182997252,OT,,,182997252,1,2007,2018,,,182997252,1,HIV infection
18306813,183068132,2,F,,20210308,20200924,20210316,EXP,,CA-TEVA-2020-CA-1830320,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,EFAVIRENZ.,Depression;Drug interaction;Loss of personal independence in daily activities,183068132,OT,,,,,,,,,183068132,1,HIV infection
18320424,183204242,2,F,,20200915,20200929,20210112,EXP,,IN-CIPLA LTD.-2020IN06604,CIPLA,"SUDHARSHAN S, KUMAR KD, BHENDE M, BISWAS J, SELVAMUTHU P. EFAVIRENZ?ASSOCIATED RETINAL TOXICITY PRESENTING WITH NIGHT VISION DEFECTS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS. OCULAR IMMUNOLOGY AND INFLAMMATION. 2020?1 TO 9",,,,,Y,,,20210112,,HP,IN,IN,EFAVIRENZ.,Retinal toxicity,183204242,OT,,,,,,,,,183204242,1,HIV infection
18320586,183205862,2,F,,20200915,20200929,20210112,EXP,,IN-CIPLA LTD.-2020IN06851,CIPLA,"SUDHARSHAN S, KUMAR KD, BHENDE M, BISWAS J, SELVAMUTHU P.. EFAVIRENZ?ASSOCIATED RETINAL TOXICITY PRESENTING WITH NIGHT VISION DEFECTS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS. OCULAR IMMUNOLOGY AND INFLAMMATION. 2020?1 TO 9",,,,,Y,,,20210112,,MD,IN,IN,EFAVIRENZ.,Retinal toxicity,183205862,OT,,,,,,,,,183205862,1,HIV infection
18320592,183205922,2,F,,20200915,20200929,20210112,EXP,,IN-CIPLA LTD.-2020IN06850,CIPLA,"SUDHARSHAN S, KUMAR KD, BHENDE M, BISWAS J, SELVAMUTHU P.. EFAVIRENZ?ASSOCIATED RETINAL TOXICITY PRESENTING WITH NIGHT VISION DEFECTS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS. OCULAR IMMUNOLOGY AND INFLAMMATION. 2020?1 TO 9",,,,,Y,,,20210112,,HP,IN,IN,EFAVIRENZ.,Retinal toxicity,183205922,OT,,,,,,,,,183205922,1,HIV infection
18320599,183205992,2,F,,20200915,20200929,20210112,EXP,,IN-CIPLA LTD.-2020IN06844,CIPLA,"SUDHARSHAN S, KUMAR KP, BHENDE M, BISWAS J, SELVAMUTHU P. EFAVIRENZ?ASSOCIATED RETINAL TOXICITY PRESENTING WITH NIGHT VISION DEFECTS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS. OCULAR IMMUNOLOGY AND INFLAMMATION. 2020?1 TO 10",,,,,Y,,,20210112,,HP,IN,IN,EFAVIRENZ.,Retinal toxicity,183205992,OT,,,,,,,,,183205992,1,HIV infection
18320601,183206012,2,F,,20200915,20200929,20210112,EXP,,IN-CIPLA LTD.-2020IN06847,CIPLA,"SUDHARSHAN S, KUMAR KD, BHENDE M, BISWAS J, SELVAMUTHU P.. EFAVIRENZ?ASSOCIATED RETINAL TOXICITY PRESENTING WITH NIGHT VISION DEFECTS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS. OCULAR IMMUNOLOGY AND INFLAMMATION. 2020?1 TO 9",,,,,Y,,,20210112,,HP,IN,IN,EFAVIRENZ.,Retinal toxicity,183206012,OT,,,,,,,,,183206012,1,HIV infection
18322906,183229062,2,F,,20210308,20200928,20210311,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-075418,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210311,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction,183229062,HO,,,,,,,,,183229062,1,Product used for unknown indication
18322942,183229422,2,F,,20210309,20200928,20210311,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-075279,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210311,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Off label use;Prescribed overdose,183229422,OT,,,,,,,,,183229422,1,HIV infection
18336818,183368185,5,F,,20210325,20201001,20210330,EXP,,CA-009507513-1902CAN006433,MERCK,,44,YR,,M,Y,,,20210330,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,183368185,OT,,,,,,,,,183368185,1,HIV infection
18349618,183496182,2,F,,20210315,20201006,20210326,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK194023,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210326,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,183496182,OT,,,,,,,,,183496182,1,Bipolar disorder
18349627,183496272,2,F,,20210315,20201006,20210326,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2020GSK194023,VIIV,,54,YR,,M,Y,,,20210326,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,183496272,OT,,,,,,,,,183496272,1,Bipolar disorder
18376368,183763682,2,F,201707,20200930,20201013,20210112,EXP,,IN-CIPLA LTD.-2020IN07156,CIPLA,"PRABHU V, COELHO S, ACHAPPA B, BALIGA S, SHARON L, SHAH J.. ROLE OF FLUORESCENCE IN SITU HYBRIDIZATION IN DETECTING MYCOBACTERIUM AVIUM COMPLEX PRESENTING AS FEVER IN TREATMENT FAILURE HIV. J CLIN TUBERC OTHER MYCOBACT DIS. 2020?21 (100188):1 TO 3",,,,,Y,,,20210112,,HP,IN,IN,EFAVIRENZ.,Fatigue;Mycobacterium avium complex infection;Somnolence;Treatment failure;Treatment noncompliance,183763682,HO,,,,,,,,,183763682,1,HIV infection
18387262,183872623,3,F,2016,20210307,20201015,20210312,EXP,,US-GILEAD-2020-0498473,GILEAD,,,,A,M,Y,,,20210312,,LW,US,US,SUSTIVA,Bone density decreased;Osteopenia;Osteoporosis;Spinal disorder;Spinal stenosis;Tooth loss,183872623,OT,,,183872623,1,2006,2016,,,183872623,1,HIV infection
18420531,184205313,3,F,2007,20210204,20201023,20210219,EXP,,US-GILEAD-2020-0499315,GILEAD,,64,YR,A,M,Y,113.38,KG,20210219,,LW,US,US,SUSTIVA,Acute kidney injury;Back pain;Bone density decreased;Chronic kidney disease;Condition aggravated;Decreased activity;Depression;Emotional distress;Pain;Post-traumatic stress disorder;Renal failure;Renal impairment,184205313,HO,,,184205313,1,2003,201205,,,184205313,1,HIV infection
18429118,184291182,2,F,,20210216,20201026,20210223,EXP,,CA-BAUSCH-BL-2020-030678,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,EFAVIRENZ.,Depression;Drug interaction;Loss of personal independence in daily activities,184291182,OT,,,,,,,,,184291182,1,Bipolar disorder
18441452,184414522,2,F,20171006,20210115,20201029,20210129,EXP,,US-GILEAD-2020-0501284,GILEAD,,61,YR,A,F,Y,,,20210129,,LW,US,US,SUSTIVA,Ankle fracture;Fracture,184414522,OT,,,184414522,1,20061231,20180101,,,184414522,1,HIV infection
18442863,184428632,2,F,201804,20210111,20201030,20210126,PER,,US-GILEAD-2020-0501285,GILEAD,,71,YR,E,F,Y,,,20210126,,LW,US,US,SUSTIVA,Acute kidney injury;Tooth loss,184428632,DE,,,184428632,1,20150206,20161018,,,184428632,1,HIV infection
18468672,184686722,2,F,20180822,20201101,20201105,20210302,EXP,,ZA-VIIV HEALTHCARE LIMITED-ZA2020GSK216742,VIIV,,41,YR,,F,Y,,,20210302,,MD,ZA,ZA,EFAVIRENZ.,Abortion spontaneous;Exposure during pregnancy,,,,,184686722,1,20171204,20180814,,,184686722,1,HIV infection
18471219,184712192,2,F,,20201027,20201106,20210112,EXP,,IN-CIPLA LTD.-2020IN07831,CIPLA,,,,,,Y,,,20210112,,HP,IN,IN,EFAVIRENZ.,Exposure via breast milk;Foetal exposure during pregnancy;Low birth weight baby,184712192,OT,,,,,,,,,,,
18498381,184983812,2,F,,20210223,20201113,20210226,EXP,,FR-ABBVIE-20K-056-3643688-00,ABBVIE,,,,N,M,Y,,,20210226,,CN,US,FR,EFAVIRENZ.,Foetal exposure during pregnancy;Hydrocele,184983812,CA,,,184983812,8,20070512,,,,184983812,1,Maternal exposure timing unspecified
18553185,185531854,4,F,20200917,20210201,20201127,20210208,EXP,,ZA-AUROBINDO-AUR-APL-2020-058798,AUROBINDO,,29,YR,,F,Y,,,20210208,,HP,ZA,ZA,Efavirenz+Emtricitabine+Tenofovir,Abortion induced;Maternal exposure during pregnancy,185531854,OT,,,185531854,1,20200901,20200910,,,185531854,1,Product used for unknown indication
18569619,185696192,2,F,,20201130,20201202,20210104,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-08814,LUPIN,,29,YR,,F,Y,,,20210104,,HP,US,US,EFAVIRENZ.,Exposure during pregnancy,,,,,,,,,,,185696192,1,HIV infection
18663452,186634522,2,F,201810,20201211,20201224,20210127,EXP,,US-009507513-2012USA011140,MERCK,,,,,F,Y,,,20210127,,LW,US,US,SUSTIVA,Ankle fracture;Bone density decreased;Bone loss;Multiple fractures;Osteonecrosis;Osteoporosis;Renal injury;Skeletal injury,186634522,OT,,,186634522,3,2004,,,,186634522,1,HIV infection
18690324,186903241,1,I,,20201103,20210101,20210101,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-08819,LUPIN,,29,YR,,F,Y,,,20210101,,HP,US,US,EFAVIRENZ.,Exposure during pregnancy;Premature delivery,,,,,,,,,,,186903241,1,HIV infection
18690345,186903451,1,I,,20201103,20210101,20210101,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-08824,LUPIN,,34,YR,,F,Y,,,20210101,,HP,US,US,EFAVIRENZ.,Exposure during pregnancy;Normal newborn,,,,,,,,,,,186903451,1,HIV infection
18703266,187032661,1,I,,20200320,20210105,20210105,PER,,IN-LUPIN LIMITED-2020-01682,LUPIN,,58,YR,,F,Y,,,20210106,,HP,IN,IN,EFAVIRENZ.,Drug eruption;Drug hypersensitivity;Renal tubular acidosis,187032661,OT,,,,,,,,,187032661,1,HIV infection
18703934,187039342,2,F,201810,20210125,20210106,20210208,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-111175,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20210208,,LW,US,US,SUSTIVA,Ankle fracture;Bone density decreased;Bone loss;Multiple fractures;Osteonecrosis;Osteoporosis;Renal injury;Skeletal injury,187039342,OT,,,187039342,3,2004,,,,187039342,1,HIV infection
18705278,187052781,1,I,20090326,20200528,20210106,20210106,EXP,,US-GILEAD-2021-0511357,GILEAD,,34,YR,A,M,Y,78.93,KG,20210106,,CN,US,US,SUSTIVA,"Acute kidney injury;Anxiety;Chronic kidney disease;Clavicle fracture;Delusional disorder, unspecified type;Depression;End stage renal disease;Renal failure;Tooth loss",187052781,OT,,,187052781,1,2004,2013,,,187052781,1,HIV infection
18710148,187101483,3,F,20201125,20210219,20210107,20210329,EXP,,FR-AUROBINDO-AUR-APL-2021-000435,AUROBINDO,,57,YR,,M,Y,60,KG,20210329,,MD,FR,FR,Efavirenz+Emtricitabine+Tenofovir Film  coated Tablets,Drug ineffective;Drug interaction;Viral load increased,187101483,OT,,,,,,,,,187101483,1,HIV infection
18714581,187145812,2,F,2012,20210212,20210107,20210218,EXP,,AU-ABBVIE-21K-008-3715700-00,ABBVIE,,52,YR,,F,Y,,,20210218,,HP,AU,AU,EFAVIRENZ.,Behaviour disorder;Central nervous system inflammation;Cerebellar syndrome;Chorea;Confusional state;Disorientation;Dysarthria;Dysdiadochokinesis;Gait disturbance;HIV-associated neurocognitive disorder;Hypophagia;Loss of personal independence in daily activities;Magnetic resonance imaging brain abnormal;Meningitis viral;Meningoencephalitis viral;Parainfluenzae virus infection;Past-pointing;Pathogen resistance;Rhinitis;Treatment noncompliance;Viraemia;Viral mutation identified,187145812,HO,,,187145812,2,2012,,,,187145812,1,Product used for unknown indication
18714732,187147322,2,F,20100215,20210202,20210107,20210205,EXP,,US-GILEAD-2021-0511881,GILEAD,,48,YR,A,F,Y,,,20210205,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Deep vein thrombosis,187147322,OT,,,187147322,2,201607,,,,187147322,1,HIV infection
18715970,187159701,1,I,,20210105,20210108,20210108,EXP,,NVSC2021IT002377,NOVARTIS,"OLTOLIN C, PIEMONTESE S, RIPA M, GRECO R, NOZZA S, CORTI C ET AL.. LLOGENEIC BONE MARROW TRANSPLANTATION IN HIV PEOPLE WITH HEMATOLOGICAL MALIGNANCIES: POST?TRANSPLANT CYCLOPHOSPHAMIDE TO OVERCOME THE HLA?MATCHING BARRIER. TRANSPLANT INFECTIOUS DISEASE. 2021?0(0):E13551",57,YR,,F,Y,,,20210108,,HP,IT,IT,EFAVIRENZ.,Graft versus host disease in skin;Human herpesvirus 6 infection reactivation;Pancytopenia;Pneumonia bacterial;Product use in unapproved indication,187159701,OT,,,,,,,,,187159701,1,Prophylaxis against graft versus host disease
18716418,187164181,1,I,20180115,20201230,20210108,20210108,EXP,,ES-STRIDES ARCOLAB LIMITED-2021SP000073,STRIDES,,50,YR,,F,Y,,,20210108,,HP,ES,ES,EFAVIRENZ.,Haemolytic anaemia,187164181,HO,,,187164181,1,2015,20180123,,,187164181,1,HIV infection
18724742,187247422,2,F,,20210108,20210111,20210204,EXP,,US-GILEAD-2021-0512233,GILEAD,,,,A,F,Y,,,20210204,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Colon cancer,187247422,OT,,,,,,,,,187247422,1,HIV infection
18727592,187275921,1,I,201912,20210105,20210111,20210111,EXP,,US-GILEAD-2021-0511928,GILEAD,,74,YR,E,F,Y,,,20210111,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abdominal pain upper;Arthralgia;CD4 lymphocytes decreased;Coronavirus infection;Pulmonary function test decreased;Visual impairment,187275921,DS,,,187275921,1,201912,,,,187275921,1,Product used for unknown indication
18731963,187319631,1,I,,20210104,20210112,20210112,EXP,,US-GILEAD-2021-0512196,GILEAD,,36,YR,A,M,Y,,,20210112,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Gait inability;Hallucination;Insomnia;Loss of consciousness;Multiple sclerosis relapse,187319631,OT,,,,,,,,,187319631,1,HIV infection
18740739,187407392,2,F,,20210120,20210114,20210128,PER,,RU-BEH-2021127234,CSL BEHRING,"PETRENKO A.A., DUDINA G.A., KREMNEVA N.V., PIVNIK A.V.. PARVOVIRUS B19 INFECTION IN HIV?INFECTED PATIENTS. TER ARKH. 2020?92 (7):100?103",32,YR,A,F,Y,,,20210128,,HP,RU,RU,EFAVIRENZ.,Drug ineffective for unapproved indication;Off label use,,,,,187407392,1,201809,201903,,,187407392,1,Parvovirus B19 infection
18741267,187412672,2,F,,20210202,20210114,20210205,PER,,US-GILEAD-2021-0512641,GILEAD,,64,YR,A,M,Y,87,KG,20210205,,CN,US,US,EFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE,Hot flush;Insomnia;Night sweats,,,,,187412672,1,2001,,,,187412672,1,Product used for unknown indication
18746305,187463051,1,I,2004,20210112,20210115,20210115,EXP,,PT-GILEAD-2021-0512624,GILEAD,,21,YR,A,M,Y,,,20210115,,MD,PT,PT,EFAVIRENZ.,Alcoholism;Drug resistance;Myocardial infarction;Pancreatitis acute;Pathogen resistance;Treatment noncompliance,187463051,OT,,,187463051,1,2004,2010,,,187463051,1,Product used for unknown indication
18750981,187509811,1,I,2009,20210113,20210118,20210118,EXP,,US-GILEAD-2021-0513037,GILEAD,,58,YR,A,M,Y,,,20210118,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Bone disorder;Nightmare;Osteoporosis,187509811,OT,,,187509811,1,,2018,,,187509811,1,HIV infection
18751634,187516341,1,I,,20210112,20210118,20210118,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-076311",BOEHRINGER INGELHEIM,,45,YR,A,M,Y,,,20210117,,HP,CA,CA,EFAVIRENZ.,Multiple-drug resistance,187516341,OT,,,,,,,,,187516341,1,HIV infection
18755838,187558381,1,I,2004,20210112,20210119,20210119,EXP,,PT-VIIV HEALTHCARE LIMITED-PT2021010113,VIIV,,21,YR,,M,Y,,,20210119,,MD,PT,PT,EFAVIRENZ.,Alcoholism;Drug resistance;Myocardial infarction;Pancreatitis acute;Pathogen resistance;Treatment noncompliance,187558381,HO,,,187558381,1,2007,2010,,,187558381,1,Product used for unknown indication
18755857,187558571,1,I,2004,20210112,20210119,20210119,EXP,,PT-GLAXOSMITHKLINE-PT2021010113,GLAXOSMITHKLINE,,21,YR,,M,Y,,,20210119,,MD,PT,PT,EFAVIRENZ.,Alcoholism;Drug resistance;Myocardial infarction;Pancreatitis acute;Pathogen resistance;Treatment noncompliance,187558571,HO,,,187558571,1,2007,2010,,,187558571,1,Product used for unknown indication
18757307,187573071,1,I,,20210111,20210119,20210119,EXP,,CA-BAXTER-2021BAX000776,BAXTER,,,,,,Y,,,20210119,,HP,CA,CA,EFAVIRENZ.,Acute kidney injury;Alanine aminotransferase increased;Anaemia;Aspartate aminotransferase increased;Blood bilirubin increased;Cerebral ischaemia;Cystitis noninfective;Drug interaction;Febrile neutropenia;Haematuria;Infection;Myalgia;Pulmonary embolism;Seizure;Thrombosis;Tumour lysis syndrome;Vomiting,187573071,OT,,,,,,,,,187573071,1,Diffuse large B-cell lymphoma
18761468,187614681,1,I,,20210105,20210119,20210119,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-000686,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210119,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,187614681,OT,,,,,,,,,187614681,1,HIV infection
18763728,187637281,1,I,,20210112,20210120,20210120,EXP,,CA-JNJFOC-20210120667,JOHNSON AND JOHNSON,,,,,,Y,,,20210120,,HP,CA,CA,EFAVIRENZ.,Acute kidney injury;Alanine aminotransferase increased;Anaemia;Aspartate aminotransferase increased;Blood bilirubin increased;Cerebral ischaemia;Cystitis noninfective;Drug interaction;Febrile neutropenia;Haematuria;Infection;Myalgia;Pulmonary embolism;Seizure;Thrombosis;Tumour lysis syndrome;Vomiting,187637281,OT,,,,,,,,,187637281,1,HIV infection
18768016,187680161,1,I,,20210115,20210121,20210121,EXP,,US-GILEAD-2021-0513663,GILEAD,,56,YR,A,M,Y,,,20210121,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Arthritis;Hip arthroplasty;Knee arthroplasty;Tooth fracture,187680161,OT,,,,,,,,,187680161,1,HIV infection
18768161,187681611,1,I,,20201210,20210121,20210121,EXP,,MY-CIPLA LTD.-2021MY00375,CIPLA,,,,,,Y,,,20210121,,HP,MY,MY,EFAVIR (EFAVIRENZ),Alanine aminotransferase increased;Aspartate aminotransferase increased;Blood bilirubin increased;Coagulation factor increased;Lactic acidosis;Rash,187681611,OT,,,,,,,,,187681611,1,Antiretroviral therapy
18768162,187681621,1,I,,20201210,20210121,20210121,EXP,,MY-CIPLA LTD.-2021MY00407,CIPLA,,,,,,Y,,,20210121,,HP,MY,MY,EFAVIR (EFAVIRENZ),Productive cough;Pyrexia;Rash;Rash maculo-papular;Rhinorrhoea,187681621,OT,,,,,,,,,187681621,1,Antiretroviral therapy
18768168,187681681,1,I,,20201210,20210121,20210121,EXP,,MY-CIPLA LTD.-2021MY00408,CIPLA,,,,,,Y,,,20210121,,HP,MY,MY,EFAVIR (EFAVIRENZ),Eye pruritus;Rash maculo-papular;Rash pruritic;Swelling;Swelling face,187681681,OT,,,,,,,,,187681681,1,Antiretroviral therapy
18775907,187759071,1,I,20191201,20201218,20210122,20210122,EXP,,US-GILEAD-2020-0510261,GILEAD,,46,YR,A,M,Y,,,20210122,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Bone density decreased;Rash;Renal injury;Weight increased,187759071,OT,,,187759071,1,20090501,20191231,,,187759071,1,HIV infection
18776215,187762153,3,F,201912,20210209,20210123,20210224,PER,,GB-LUPIN PHARMACEUTICALS INC.-2021-00424,LUPIN,,28,YR,,F,Y,,,20210224,,CN,GB,GB,EFAVIRENZ.,Breast mass;Breast pain;Breast swelling;Insomnia,,,,,187762153,1,201709,,,,187762153,1,HIV infection
18779815,187798152,2,F,201812,20210122,20210125,20210201,EXP,,GB-GILEAD-2021-0513018,GILEAD,,38,YR,A,F,Y,,,20210201,,PH,GB,GB,EFAVIRENZ.,Oesophageal ulcer,187798152,OT,,,187798152,1,201609,201810,,,187798152,1,HIV infection
18782541,187825411,1,I,,20210119,20210125,20210125,EXP,,CA-009507513-2101CAN009446,MERCK,,,,,M,Y,,,20210125,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction,187825411,OT,,,,,,,,,187825411,1,Product used for unknown indication
18784938,187849381,1,I,,20210118,20210125,20210125,EXP,,CA-BAUSCH-BL-2021-002497,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210125,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,187849381,OT,,,,,,,,,187849381,1,Product used for unknown indication
18787463,187874631,1,I,201812,20210122,20210126,20210126,EXP,GB-MHRA-MIDB-25B82B98-3A93-4248-A2A0-FC7337FC2E0F,GB-MYLANLABS-2021M1004747,MYLAN,,38,YR,,F,Y,,,20210126,,PH,GB,GB,EFAVIRENZ.,Oesophageal ulcer,187874631,HO,,,187874631,1,201810,,,,187874631,1,HIV test
18798418,187984181,1,I,2006,20210118,20210128,20210128,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-004665,BRISTOL MYERS SQUIBB,,57,YR,,M,Y,,,20210128,,MD,DE,DE,SUSTIVA,Abdominal mass;Coronary artery disease;Glomerular filtration rate decreased;Hypercholesterolaemia;Hypertension;Lipoatrophy;Proteinuria;Viraemia,187984181,OT,,,187984181,1,1997,,,,187984181,1,HIV infection
18802325,188023251,1,I,,20210118,20210128,20210128,EXP,,US-VIIV HEALTHCARE LIMITED-TZ2021GSK020417,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210128,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188023251,OT,,,,,,,,,188023251,1,HIV infection
18802328,188023281,1,I,,20210118,20210128,20210128,EXP,,US-GLAXOSMITHKLINE-TZ2021GSK020417,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210128,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188023281,OT,,,,,,,,,188023281,1,HIV infection
18802373,188023731,1,I,,20210118,20210128,20210128,EXP,,US-VIIV HEALTHCARE LIMITED-TZ2021GSK020418,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210128,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188023731,OT,,,,,,,,,188023731,1,HIV infection
18802374,188023741,1,I,,20210118,20210128,20210128,EXP,,US-GLAXOSMITHKLINE-TZ2021GSK020418,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210128,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188023741,OT,,,,,,,,,188023741,1,HIV infection
18802498,188024981,1,I,,20210118,20210128,20210128,EXP,,US-GLAXOSMITHKLINE-TZ2021GSK020419,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210128,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188024981,OT,,,,,,,,,188024981,1,HIV infection
18802500,188025001,1,I,,20210118,20210128,20210128,EXP,,US-VIIV HEALTHCARE LIMITED-TZ2021GSK020419,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210128,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188025001,OT,,,,,,,,,188025001,1,HIV infection
18806515,188065151,1,I,,20210125,20210129,20210129,EXP,,MX-GILEAD-2021-0514771,GILEAD,,30,YR,A,M,Y,,,20210129,,CN,MX,MX,EFAVIRENZ.,Hallucination;Poor quality sleep;Product use issue;Somnolence,188065151,OT,,,188065151,1,201706,201901,,,188065151,1,HIV infection
18808889,188088891,1,I,,20210118,20210129,20210129,EXP,,US-VIIV HEALTHCARE LIMITED-DO2021GSK020449,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,DO,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188088891,OT,,,,,,,,,188088891,1,HIV infection
18808891,188088911,1,I,,20210118,20210129,20210129,EXP,,US-GLAXOSMITHKLINE-DO2021GSK020449,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,DO,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188088911,OT,,,,,,,,,188088911,1,HIV infection
18809081,188090811,1,I,,20210118,20210129,20210129,EXP,,US-GLAXOSMITHKLINE-DO2021GSK020451,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,DO,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188090811,OT,,,,,,,,,188090811,1,HIV infection
18809082,188090821,1,I,,20210118,20210129,20210129,EXP,,US-VIIV HEALTHCARE LIMITED-DO2021GSK020451,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,DO,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188090821,OT,,,,,,,,,188090821,1,HIV infection
18809304,188093041,1,I,,20210122,20210129,20210129,EXP,,GB-009507513-2101GBR011114,MERCK,,,,,F,Y,,,20210129,,CN,GB,GB,EFAVIRENZ.,Ill-defined disorder,188093041,HO,,,,,,,,,,,
18809321,188093211,1,I,,20210118,20210129,20210129,EXP,,US-VIIV HEALTHCARE LIMITED-DO2021GSK020452,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,DO,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188093211,OT,,,,,,,,,188093211,1,HIV infection
18809325,188093251,1,I,,20210118,20210129,20210129,EXP,,US-GLAXOSMITHKLINE-DO2021GSK020452,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,DO,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188093251,OT,,,,,,,,,188093251,1,HIV infection
18809622,188096221,1,I,,20210118,20210129,20210129,EXP,,US-GLAXOSMITHKLINE-DO2021GSK020448,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,DO,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188096221,OT,,,,,,,,,188096221,1,HIV infection
18809623,188096231,1,I,,20210118,20210129,20210129,EXP,,US-VIIV HEALTHCARE LIMITED-DO2021GSK020448,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,DO,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188096231,OT,,,,,,,,,188096231,1,HIV infection
18810411,188104111,1,I,,20210118,20210129,20210129,EXP,,US-VIIV HEALTHCARE LIMITED-TZ2021GSK020420,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188104111,OT,,,,,,,,,188104111,1,HIV infection
18810413,188104131,1,I,,20210118,20210129,20210129,EXP,,US-GLAXOSMITHKLINE-TZ2021GSK020420,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188104131,OT,,,,,,,,,188104131,1,HIV infection
18810712,188107121,1,I,,20210118,20210129,20210129,EXP,,US-VIIV HEALTHCARE LIMITED-TZ2021GSK020421,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188107121,OT,,,,,,,,,188107121,1,HIV infection
18810716,188107161,1,I,,20210118,20210129,20210129,EXP,,US-GLAXOSMITHKLINE-TZ2021GSK020421,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188107161,OT,,,,,,,,,188107161,1,HIV infection
18810764,188107642,2,F,,20210125,20210129,20210218,EXP,,MX-GILEAD-2021-0515071,GILEAD,,30,YR,A,M,Y,,,20210218,,CN,MX,MX,EFAVIRENZ.,Hallucination;Poor quality sleep;Product dose omission in error;Somnolence,188107642,OT,,,188107642,1,201706,201901,,,188107642,1,HIV infection
18810877,188108771,1,I,,20210118,20210129,20210129,EXP,,US-GLAXOSMITHKLINE-TZ2021GSK020422,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188108771,OT,,,,,,,,,188108771,1,HIV infection
18810880,188108801,1,I,,20210118,20210129,20210129,EXP,,US-VIIV HEALTHCARE LIMITED-TZ2021GSK020422,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188108801,OT,,,,,,,,,188108801,1,HIV infection
18810978,188109781,1,I,,20210118,20210129,20210129,EXP,,US-VIIV HEALTHCARE LIMITED-TZ2021GSK020424,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188109781,OT,,,,,,,,,188109781,1,HIV infection
18810979,188109791,1,I,,20210118,20210129,20210129,EXP,,US-VIIV HEALTHCARE LIMITED-TZ2021GSK020423,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188109791,OT,,,,,,,,,188109791,1,HIV infection
18810981,188109811,1,I,,20210118,20210129,20210129,EXP,,US-GLAXOSMITHKLINE-TZ2021GSK020423,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188109811,OT,,,,,,,,,188109811,1,HIV infection
18810992,188109921,1,I,,20210118,20210129,20210129,EXP,,US-GLAXOSMITHKLINE-TZ2021GSK020424,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188109921,OT,,,,,,,,,188109921,1,HIV infection
18811115,188111151,1,I,,20210118,20210129,20210129,EXP,,US-VIIV HEALTHCARE LIMITED-TZ2021GSK020425,VIIV,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188111151,OT,,,,,,,,,188111151,1,HIV infection
18811117,188111171,1,I,,20210118,20210129,20210129,EXP,,US-GLAXOSMITHKLINE-TZ2021GSK020425,GLAXOSMITHKLINE,"GRANT?MCAULEY W, FOGEL JM, GALAI N, CLARKE W, BREAUD A, MARZINKE MA ET AL. ANTIRETROVIRAL DRUG USE AND HIV DRUG RESISTANCE IN FEMALE SEX WORKERS IN TANZANIA AND THE DOMINICAN REPUBLIC. PLOS ONE. 2020?15 (10)",,,,F,Y,,,20210129,,HP,US,TZ,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,188111171,OT,,,,,,,,,188111171,1,HIV infection
18818695,188186951,1,I,,20210122,20210201,20210201,EXP,GB-MHRA-MIDB-25B82B98-3A93-4248-A2A0-FC7337FC2E0F,GB-009507513-2101GBR011304,MERCK,,38,YR,,F,Y,,,20210201,,PH,GB,GB,EFAVIRENZ.,Oesophageal ulcer,188186951,HO,,,,,,,,,188186951,1,HIV test
18819739,188197391,1,I,,20210125,20210202,20210202,EXP,,IT-AUROBINDO-AUR-APL-2021-004140,AUROBINDO,,51,YR,,,Y,,,20210202,,CN,IT,IT,Efavirenz+Emtricitabine+Tenofovir Film  coated Tablets,Drug ineffective,188197391,OT,,,,,,,,,188197391,1,HIV infection
18832051,188320511,1,I,20171006,20210115,20210203,20210203,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-009871,BRISTOL MYERS SQUIBB,,61,YR,,F,Y,,,20210203,,LW,US,US,SUSTIVA,Ankle fracture;Fracture,188320511,OT,,,188320511,1,199812,20060801,,,188320511,1,HIV infection
18833406,188334061,1,I,,20210122,20210203,20210203,EXP,,GB-MACLEODS PHARMACEUTICALS US LTD-MAC2021029952,MACLEODS,,,,,,Y,,,20210203,,CN,GB,GB,EFAVIRENZ.,Oesophageal ulcer,188334061,HO,,,188334061,3,201810,,,,188334061,1,HIV test
18843044,188430441,1,I,,20210127,20210204,20210204,EXP,,GB-MYLANLABS-2021M1006850,MYLAN,"NDERITU P, RIGA P, MANN S, GARNAVOU?XIROU C, ELEFTHERIADIS H. DIDANOSINE?ASSOCIATED RETINAL TOXICITY (DART) AMONGST HIV?POSITIVE PATIENTS: A CASE SERIES AND LITERATURE REVIEW. SN?COMPR?CLIN?MED 2020?2:2939?2952.",73,YR,,F,Y,,,20210204,,MD,GB,GB,EFAVIRENZ.,Disease progression;Retinal toxicity,188430441,OT,,,188430441,1,2013,2007,,,188430441,1,HIV infection
18845707,188457072,2,F,,20210205,20210204,20210216,PER,,RU-LUPIN PHARMACEUTICALS INC.-2021-01009,LUPIN,,32,YR,,F,Y,,,20210216,,HP,RU,RU,EFAVIRENZ.,Drug ineffective,188457072,DE,,,188457072,1,201809,201808,,,188457072,1,Parvovirus B19 infection
18849507,188495071,1,I,,20210201,20210204,20210204,EXP,,GB-MYLANLABS-2021M1006774,MYLAN,,,,,F,Y,,,20210204,,CN,GB,GB,EFAVIRENZ.,Ill-defined disorder,188495071,HO,,,,,,,,,188495071,1,Product used for unknown indication
18849877,188498772,2,F,2018,20210130,20210205,20210205,EXP,,VN-CIPLA LTD.-2021VN00764,CIPLA,,,,,,Y,,,20210205,,HP,VN,VN,EFAVIRENZ.,Abdominal distension;Abdominal pain;Immune reconstitution inflammatory syndrome;Penicillium infection;Septic shock,188498772,HO,,,188498772,1,20180107,,,,188498772,1,HIV infection
18851168,188511682,2,F,201706,20210130,20210205,20210208,EXP,,VN-CIPLA LTD.-2021VN00763,CIPLA,,,,,,Y,,,20210208,,MD,VN,VN,EFAVIRENZ.,Treatment failure,188511682,OT,,,188511682,1,,201706,,,188511682,1,HIV infection
18851252,188512521,1,I,,20210128,20210205,20210205,EXP,,CN-GILEAD-2021-0515348,GILEAD,"SHUWEN J, CANYE M, FAN Y, RUIXIANG H, JIANXUE W, BAOJIN L, CUNCHUAN W. 1 CASE REPORT OF LAPAROSCOPIC SLEEVE GASTRECTOMY IN A PATIENT WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND OBESITY. CHIN J OBES METAB DIS.. 2020?6:259?261. DOI:10.3877/CMA.J.ISSN.2095?9605.2020.04.011",29,YR,A,M,Y,,,20210205,,MD,CN,CN,EFAVIRENZ.,Blood calcium decreased;Osteoporosis,188512521,OT,,,,,,,,,188512521,1,HIV infection
18855116,188551161,1,I,,20210122,20210205,20210205,EXP,GB-MHRA-MIDB-25B82B98-3A93-4248-A2A0-FC7337FC2E0F,GB-TEVA-2021-GB-1874864,TEVA,,38,YR,A,F,Y,,,20210205,,PH,GB,GB,EFAVIRENZ.,Oesophageal ulcer,188551161,HO,,,,,,,,,188551161,1,HIV test
18855729,188557292,2,F,,20210205,20210205,20210212,EXP,,AU-GILEAD-2021-0516233,GILEAD,,,,,F,Y,,,20210212,,CN,AU,AU,EFAVIRENZ.,Behaviour disorder;Central nervous system inflammation;Cerebellar syndrome;Chorea;Confusional state;Disorientation;Dysarthria;Dysdiadochokinesis;Gait disturbance;HIV-associated neurocognitive disorder;Hypophagia;Loss of personal independence in daily activities;Magnetic resonance imaging brain abnormal;Meningitis viral;Meningoencephalitis viral;Parainfluenzae virus infection;Pathogen resistance;Rhinitis;Treatment noncompliance;Viral mutation identified,188557292,OT,,,,,,,,,188557292,1,Product used for unknown indication
18855854,188558542,2,F,,20210208,20210206,20210211,EXP,,ZA-AUROBINDO-AUR-APL-2021-005342,AUROBINDO,,59,YR,,F,Y,,,20210211,,HP,ZA,ZA,EFAVIRENZ.,Drug interaction;Drug level abnormal;Neutropenia,188558542,OT,,,,,,,,,188558542,1,Product used for unknown indication
18855898,188558981,1,I,,20210201,20210206,20210206,EXP,,RU-AUROBINDO-AUR-APL-2021-005089,AUROBINDO,,32,YR,,F,Y,,,20210206,,HP,RU,RU,EFAVIRENZ.,Drug ineffective,188558981,OT,,,188558981,1,201903,,,,188558981,1,Parvovirus B19 infection
18858522,188585221,1,I,,20210201,20210208,20210208,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-010348,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20210208,,CN,GB,GB,EFAVIRENZ.,Ill-defined disorder,188585221,HO,,,,,,,,,188585221,1,Product used for unknown indication
18860935,188609351,1,I,,20210127,20210208,20210208,EXP,,GB-LUPIN PHARMACEUTICALS INC.-2021-01350,LUPIN,,73,YR,,F,Y,,,20210208,,HP,GB,GB,EFAVIRENZ.,Disease progression;Retinal toxicity,188609351,OT,,,188609351,1,2003,2008,,,188609351,1,HIV infection
18863032,188630321,1,I,,20210204,20210208,20210208,EXP,,AU-GILEAD-2021-0516245,GILEAD,,,,,F,Y,,,20210208,,CN,AU,AU,EFAVIRENZ.,Behaviour disorder;Central nervous system inflammation;Cerebellar syndrome;Chorea;Confusional state;Disorientation;Dysarthria;Dysdiadochokinesis;Gait disturbance;HIV-associated neurocognitive disorder;Hypophagia;Loss of personal independence in daily activities;Magnetic resonance imaging brain abnormal;Meningitis viral;Meningoencephalitis viral;Parainfluenzae virus infection;Pathogen resistance;Rhinitis;Treatment noncompliance;Viral mutation identified,188630321,OT,,,,,,,,,188630321,1,Product used for unknown indication
18863391,188633911,1,I,201804,20210126,20210209,20210209,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-008411,BRISTOL MYERS SQUIBB,,71,YR,,F,Y,,,20210209,,LW,US,US,SUSTIVA,Acute kidney injury;Tooth loss,188633911,OT,,,188633911,1,201502,20161018,,,188633911,1,HIV infection
18863497,188634971,1,I,,20210127,20210209,20210209,EXP,,ZA-CIPLA LTD.-2021ZA00840,CIPLA,,,,,,Y,,,20210209,,HP,ZA,ZA,EFAVIRENZ.,Drug-induced liver injury;Hepatocellular injury,188634971,OT,,,,,,,,,188634971,1,HIV infection
18863820,188638201,1,I,,20210127,20210209,20210209,EXP,,ZA-CIPLA LTD.-2021ZA00841,CIPLA,,,,,,Y,,,20210209,,HP,ZA,ZA,EFAVIRENZ.,Drug-induced liver injury;Hepatocellular injury,188638201,HO,,,,,,,,,188638201,1,HIV infection
18863986,188639861,1,I,,20210201,20210209,20210209,EXP,,GB-AUROBINDO-AUR-APL-2021-004822,AUROBINDO,,,,,F,Y,,,20210209,,CN,GB,GB,EFAVIRENZ.,Ill-defined disorder,188639861,HO,,,,,,,,,188639861,1,Product used for unknown indication
18864315,188643151,1,I,,20210201,20210209,20210209,EXP,,ZA-GILEAD-2021-0515778,GILEAD,"MOUTON J, JOBANPUTRA N, NJUGUNA C, GUNTER H, STEWART A, MEHTA U, LAHRI S, COURT R, IGUMBOR E, MAARTENS G, COHEN K. ADULT MEDICAL EMERGENCY UNIT PRESENTATIONS DUE TO ADVERSE DRUG REACTIONS IN A SETTING OF HIGH HIV PREVALENCE. AFR J EMERG MED.. 2021?UNK:46?52. DOI:10.1016/J.AFJEM.2020.10.010",45,YR,A,F,Y,,,20210209,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Acute kidney injury;Drug-induced liver injury,188643151,OT,,,,,,,,,188643151,1,HIV infection
18864398,188643981,1,I,,20210201,20210209,20210209,EXP,,ZA-GILEAD-2021-0516372,GILEAD,"MOUTON J, JOBANPUTRA N, NJUGUNA C, GUNTER H, STEWART A, MEHTA U, LAHRI S, COURT R, IGUMBOR E, MAARTENS G, COHEN K. ADULT MEDICAL EMERGENCY UNIT PRESENTATIONS DUE TO ADVERSE DRUG REACTIONS IN A SETTING OF HIGH HIV PREVALENCE. AFR J EMERG MED.. 2021?UNK:46?52. DOI:10.1016/J.AFJEM.2020.10.010",33,YR,A,F,Y,,,20210209,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Drug-induced liver injury,188643981,OT,,,,,,,,,188643981,1,HIV infection
18864489,188644891,1,I,,20210201,20210209,20210209,EXP,,ZA-GILEAD-2021-0516373,GILEAD,"MOUTON J, JOBANPUTRA N, NJUGUNA C, GUNTER H, STEWART A, MEHTA U, LAHRI S, COURT R, IGUMBOR E, MAARTENS G, COHEN K. ADULT MEDICAL EMERGENCY UNIT PRESENTATIONS DUE TO ADVERSE DRUG REACTIONS IN A SETTING OF HIGH HIV PREVALENCE. AFR J EMERG MED.. 2021?UNK:46?52. DOI:10.1016/J.AFJEM.2020.10.010",38,YR,A,F,Y,,,20210209,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Drug-induced liver injury,188644891,OT,,,,,,,,,188644891,1,HIV infection
18864664,188646641,1,I,,20210201,20210209,20210209,EXP,,ZA-GILEAD-2021-0516374,GILEAD,"MOUTON J, JOBANPUTRA N, NJUGUNA C, GUNTER H, STEWART A, MEHTA U, LAHRI S, COURT R, IGUMBOR E, MAARTENS G, COHEN K. ADULT MEDICAL EMERGENCY UNIT PRESENTATIONS DUE TO ADVERSE DRUG REACTIONS IN A SETTING OF HIGH HIV PREVALENCE. AFR J EMERG MED.. 2021?UNK:46?52. DOI:10.1016/J.AFJEM.2020.10.010",32,YR,A,F,Y,,,20210209,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Drug-induced liver injury,188646641,OT,,,,,,,,,188646641,1,HIV infection
18866523,188665231,1,I,20210105,20210126,20210208,20210208,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-012569,BRISTOL MYERS SQUIBB,,71,YR,,F,Y,,,20210208,,LW,US,US,SUSTIVA,Death,188665231,DE,,,188665231,1,201502,20161018,,,188665231,1,HIV infection
18869554,188695541,1,I,,20210127,20210210,20210210,EXP,,ZA-CIPLA LTD.-2021ZA00843,CIPLA,,,,,,Y,,,20210210,,HP,ZA,ZA,EFAVIRENZ.,Drug-induced liver injury;Mixed liver injury,188695541,HO,,,,,,,,,188695541,1,HIV infection
18870238,188702381,1,I,,20210127,20210210,20210210,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-01317,LUPIN,,27,YR,,F,Y,,,20210210,,HP,CN,CN,EFAVIRENZ.,Dermatitis allergic,188702381,OT,,,,,,,,,188702381,1,HIV infection CDC category B
18870412,188704121,1,I,,20210127,20210210,20210210,EXP,,ZA-CIPLA LTD.-2021ZA00842,CIPLA,,,,,,Y,,,20210210,,HP,ZA,ZA,EFAVIRENZ.,Cholestatic liver injury,188704121,OT,,,,,,,,,188704121,1,HIV infection
18874254,188742541,1,I,,20210207,20210210,20210210,EXP,,CA-ROCHE-2765397,ROCHE,,54,YR,,M,Y,,,20210210,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,188742541,OT,,,,,,,,,188742541,1,Product used for unknown indication
18880130,188801301,1,I,,20210201,20210211,20210211,EXP,GB-009507513-2101GBR011114,GB-VIIV HEALTHCARE LIMITED-GB2021GSK037245,VIIV,,,,,F,Y,,,20210211,,CN,GB,GB,EFAVIRENZ.,Ill-defined disorder,188801301,HO,,,,,,,,,188801301,1,Product used for unknown indication
18880146,188801461,1,I,,20210201,20210211,20210211,EXP,GB-009507513-2101GBR011114,GB-GLAXOSMITHKLINE-GB2021GSK037245,GLAXOSMITHKLINE,,,,,F,Y,,,20210211,,CN,GB,GB,EFAVIRENZ.,Ill-defined disorder,188801461,HO,,,,,,,,,188801461,1,Product used for unknown indication
18886438,188864381,1,I,,20210209,20210212,20210212,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013434,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210212,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,188864381,OT,,,,,,,,,188864381,1,HIV infection
18886499,188864991,1,I,,20210209,20210212,20210212,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013564,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210212,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,188864991,OT,,,,,,,,,188864991,1,Product used for unknown indication
18888420,188884201,1,I,,20210209,20210212,20210212,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013729,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210212,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,188884201,DE,,,,,,,,,188884201,1,Product used for unknown indication
18888480,188884801,1,I,,20210208,20210212,20210212,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013018,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210212,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,188884801,OT,,,,,,,,,188884801,1,Product used for unknown indication
18891072,188910721,1,I,,20210209,20210215,20210215,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013577,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210215,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,188910721,DE,,,,,,,,,188910721,1,Product used for unknown indication
18891109,188911091,1,I,,20210209,20210215,20210215,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013612,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210215,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Intentional product use issue;Off label use,188911091,DE,,,,,,,,,188911091,1,HIV infection
18891586,188915861,1,I,,20210209,20210215,20210215,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013598,BRISTOL MYERS SQUIBB,,44,YR,,M,Y,,,20210215,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,188915861,HO,,,,,,,,,188915861,1,HIV infection
18891596,188915961,1,I,,20210209,20210215,20210215,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013460,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210215,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,188915961,OT,,,,,,,,,188915961,1,Product used for unknown indication
18893076,188930761,1,I,,20210208,20210215,20210215,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013005,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210215,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Prescribed overdose,188930761,DE,,,,,,,,,188930761,1,HIV infection
18893253,188932531,1,I,,20210209,20210215,20210215,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013458,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210215,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Intentional product use issue,188932531,OT,,,,,,,,,188932531,1,HIV infection
18896932,188969321,1,I,,20210205,20210216,20210216,EXP,,ZA-GLAXOSMITHKLINE-US2021GSK035398,GLAXOSMITHKLINE,,,,,,Y,,,20210216,,HP,US,ZA,EFAVIRENZ.,Foetal exposure during pregnancy;HIV infection;Human immunodeficiency virus transmission,188969321,OT,,,,,,,,,188969321,1,HIV infection
18898554,188985542,2,F,,20210213,20210216,20210226,EXP,,US-MYLANLABS-2021M1009639,MYLAN,,,,,M,Y,,,20210226,,LW,US,US,EFAVIRENZ/LAMIVUDINE/TENOFOVIR,Abnormal dreams;Blood creatinine increased;Blood lactic acid increased;Dizziness;Insomnia;Liver disorder;Liver injury;Mental disorder;Nightmare;Renal failure,188985542,OT,,,188985542,1,20181012,202007,,,188985542,1,HIV infection
18899256,188992561,1,I,,20210205,20210216,20210216,EXP,,ZA-VIIV HEALTHCARE LIMITED-US2021GSK035398,VIIV,,,,,,Y,,,20210216,,HP,US,ZA,EFAVIRENZ.,Foetal exposure during pregnancy;HIV infection;Human immunodeficiency virus transmission,188992561,OT,,,,,,,,,188992561,1,HIV infection
18900413,189004131,1,I,,20210205,20210216,20210216,EXP,,ZA-GLAXOSMITHKLINE-ZA2021GSK040946,GLAXOSMITHKLINE,,,,,,Y,,,20210216,,HP,US,ZA,EFAVIRENZ.,Foetal exposure during pregnancy;HIV infection;Human immunodeficiency virus transmission,189004131,OT,,,,,,,,,189004131,1,HIV infection
18900421,189004211,1,I,,20210205,20210216,20210216,EXP,,ZA-VIIV HEALTHCARE LIMITED-ZA2021GSK040946,VIIV,,,,,,Y,,,20210216,,HP,US,ZA,EFAVIRENZ.,Foetal exposure during pregnancy;HIV infection;Human immunodeficiency virus transmission,189004211,OT,,,,,,,,,189004211,1,HIV infection
18902538,189025381,1,I,,20210212,20210217,20210217,EXP,,CA-GILEAD-2021-0517517,GILEAD,,52,YR,A,M,Y,,,20210217,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,189025381,OT,,,,,,,,,189025381,1,HIV infection
18908296,189082961,1,I,,20210208,20210218,20210218,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013003,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210218,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189082961,DE,,,,,,,,,189082961,1,Product used for unknown indication
18910584,189105841,1,I,,20210218,20210218,20210218,EXP,,CA-ROCHE-2772723,ROCHE,,54,YR,,M,Y,,,20210218,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189105841,DE,,,,,,,,,189105841,1,Bipolar disorder
18910938,189109382,2,F,,20210315,20210218,20210330,PER,,ID-LUPIN PHARMACEUTICALS INC.-2021-02011,LUPIN,,,,A,,Y,,,20210330,,HP,ID,ID,EFAVIRENZ.,Rash,,,,,,,,,,,189109382,1,HIV infection
18912879,189128791,1,I,,20210217,20210219,20210219,EXP,,CA-ROCHE-2771997,ROCHE,,54,YR,,M,Y,,,20210219,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189128791,OT,,,,,,,,,189128791,1,Bipolar disorder
18912964,189129641,1,I,,20210217,20210219,20210219,EXP,,CA-ROCHE-2772157,ROCHE,,,,,M,Y,,,20210219,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189129641,HO,,,,,,,,,189129641,1,Product used for unknown indication
18913468,189134681,1,I,,20210208,20210219,20210219,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013094,BRISTOL MYERS SQUIBB,,2,YR,,M,Y,3.2,KG,20210219,,MD,FR,FR,EFAVIRENZ.,Foetal exposure during pregnancy;Hepatic cyst;Sickle cell disease;Splenomegaly,189134681,CA,,,189134681,1,20060426,20061018,,,189134681,1,Product used for unknown indication
18915825,189158251,1,I,,20210217,20210219,20210219,EXP,,CA-ROCHE-2771981,ROCHE,,,,,M,Y,,,20210219,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189158251,DE,,,,,,,,,189158251,1,Product used for unknown indication
18916042,189160421,1,I,,20210209,20210218,20210218,EXP,,AU-JNJFOC-20210220797,JOHNSON AND JOHNSON,"BYONANEBYE D.M.,  INCIDENCE OF DYSLIPIDEMIA IN PEOPLE WITH HIV WHO ARE TREATED WITH INTEGRASE INHIBITORS VERSUS OTHER ANTIRETROVIRAL AGENTS AIDS (LONDON, ENGLAND) 2021  NO PAGINATION",,,,,Y,,,20210219,,HP,AU,AU,EFAVIRENZ.,Dyslipidaemia,189160421,OT,,,,,,,,,189160421,1,HIV infection
18917986,189179861,1,I,,20210208,20210220,20210220,EXP,,GB-AUROBINDO-AUR-APL-2021-006373,AUROBINDO,,73,YR,,F,Y,,,20210220,,HP,GB,GB,EFAVIRENZ.,Disease progression;Retinal toxicity,189179861,OT,,,189179861,1,2013,2015,,,189179861,1,HIV infection
18918274,189182741,1,I,,20210211,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006753,AUROBINDO,,,,,M,Y,,,20210220,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189182741,DE,,,,,,,,,189182741,1,Product used for unknown indication
18918336,189183361,1,I,,20210218,20210220,20210220,EXP,,CA-ROCHE-2772882,ROCHE,,,,,M,Y,,,20210220,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189183361,DE,,,,,,,,,189183361,1,Product used for unknown indication
18918632,189186322,2,F,,20210219,20210220,20210223,EXP,,CA-ROCHE-2772349,ROCHE,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189186322,OT,,,,,,,,,189186322,1,Bipolar disorder
18918726,189187261,1,I,,20200408,20210220,20210220,EXP,,CA-ROCHE-2582214,ROCHE,,44,YR,,M,Y,,,20210220,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,189187261,HO,,,,,,,,,189187261,1,Depression
18920355,189203552,2,F,,20210312,20210222,20210324,EXP,,CA-AUROBINDO-AUR-APL-2021-006862,AUROBINDO,,,,,M,Y,,,20210324,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189203552,DE,,,,,,,,,189203552,1,Product used for unknown indication
18920668,189206681,1,I,,20210218,20210222,20210222,EXP,,CA-ROCHE-2772982,ROCHE,,54,YR,,M,Y,,,20210222,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189206681,OT,,,,,,,,,189206681,1,Bipolar disorder
18921190,189211901,1,I,,20210208,20210222,20210222,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013147,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210222,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189211901,OT,,,,,,,,,189211901,1,HIV infection
18921209,189212091,1,I,,20210208,20210222,20210222,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013010,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210222,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189212091,OT,,,,,,,,,189212091,1,HIV infection
18921445,189214451,1,I,,20210212,20210222,20210222,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021044991,VIIV,,52,YR,,M,Y,,,20210222,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,189214451,OT,,,,,,,,,189214451,1,HIV infection
18921783,189217831,1,I,,20210212,20210222,20210222,EXP,,CA-GLAXOSMITHKLINE-CA2021044991,GLAXOSMITHKLINE,,52,YR,,M,Y,,,20210222,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,189217831,OT,,,,,,,,,189217831,1,HIV infection
18923545,189235451,1,I,,20210216,20210222,20210222,EXP,,CA-BAUSCH-BL-2021-006070,BAUSCH AND LOMB,,,,,M,Y,,,20210222,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189235451,OT,,,,,,,,,189235451,1,Product used for unknown indication
18923549,189235491,1,I,,20210216,20210222,20210222,EXP,,CA-BAUSCH-BL-2021-006053,BAUSCH AND LOMB,,,,,M,Y,,,20210222,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189235491,HO,,,,,,,,,189235491,1,Product used for unknown indication
18923550,189235501,1,I,,20210216,20210222,20210222,EXP,,CA-BAUSCH-BL-2021-006021,BAUSCH AND LOMB,,,,,M,Y,,,20210222,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189235501,DE,,,,,,,,,189235501,1,Product used for unknown indication
18923726,189237261,1,I,,20210209,20210222,20210222,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013581,BRISTOL MYERS SQUIBB,,44,YR,,M,Y,,,20210222,,HP,CA,CA,SUSTIVA,Anxiety,189237261,OT,,,,,,,,,189237261,1,HIV infection
18923889,189238891,1,I,,20210209,20210222,20210222,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013552,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210222,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189238891,OT,,,,,,,,,189238891,1,Product used for unknown indication
18924300,189243001,1,I,,20210208,20210222,20210222,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013104,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210222,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189243001,HO,,,,,,,,,189243001,1,Product used for unknown indication
18924449,189244491,1,I,,20210209,20210222,20210222,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013816,BRISTOL MYERS SQUIBB,,44,YR,,M,Y,,,20210222,,HP,CA,CA,SUSTIVA,Anxiety,189244491,OT,,,,,,,,,189244491,1,HIV infection
18924853,189248531,1,I,,20210209,20210222,20210222,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013583,BRISTOL MYERS SQUIBB,,44,YR,,M,Y,,,20210222,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychotic disorder;Suicidal ideation;Tearfulness,189248531,OT,,,,,,,,,189248531,1,HIV infection
18925865,189258651,1,I,,20210215,20210223,20210223,EXP,,PK-GILEAD-2021-0517535,GILEAD,"AZMI M, BABER ZU, BADLANI S, DODANI SK, NASIM A, SHEERANI M. MOVEMENT DISORDER IN A PATIENT WITH HUMAN IMMUNODEFICIENCY VIRUS ON AN ANTI?RETROVIRAL THERAPY: A CASE REPORT. J PAK MED ASSOC.. 2020?70(4):734?737. DOI:10.5455/JPMA.298947",49,YR,A,F,Y,,,20210223,,HP,PK,PK,EFAVIRENZ.,CSF HIV escape syndrome;HIV-associated neurocognitive disorder,189258651,OT,,,,,,,,,189258651,1,HIV infection
18925910,189259101,1,I,,20210211,20210222,20210222,EXP,,CA-AUROBINDO-AUR-APL-2021-006678,AUROBINDO,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189259101,DE,,,,,,,,,189259101,1,Bipolar disorder
18928763,189287631,1,I,,20210208,20210223,20210223,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013029,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Intentional product use issue,189287631,OT,,,,,,,,,189287631,1,Product used for unknown indication
18929399,189293991,1,I,,20210209,20210223,20210223,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-014017,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities,189293991,OT,,,,,,,,,189293991,1,Product used for unknown indication
18929654,189296541,1,I,,20210209,20210223,20210223,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013750,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Intentional product use issue,189296541,OT,,,,,,,,,189296541,1,HIV infection
18929664,189296641,1,I,,20210209,20210223,20210223,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013584,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Intentional product use issue,189296641,OT,,,,,,,,,189296641,1,Product used for unknown indication
18929799,189297992,2,F,,20210216,20210223,20210226,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK050509,GLAXOSMITHKLINE,,,,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189297992,OT,,,,,,,,,189297992,1,Product used for unknown indication
18929958,189299582,2,F,,20210216,20210223,20210226,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK050509,VIIV,,,,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189299582,OT,,,,,,,,,189299582,1,Product used for unknown indication
18930056,189300561,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005922,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189300561,OT,,,,,,,,,189300561,1,Bipolar disorder
18930060,189300601,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005933,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189300601,OT,,,,,,,,,189300601,1,Bipolar disorder
18930061,189300611,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005968,BAUSCH AND LOMB,,,,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189300611,HO,,,,,,,,,189300611,1,Product used for unknown indication
18930080,189300801,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005979,BAUSCH AND LOMB,,44,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychotic disorder;Suicidal ideation;Tearfulness,189300801,HO,,,,,,,,,189300801,1,Depression
18930083,189300831,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005977,BAUSCH AND LOMB,,,,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189300831,OT,,,,,,,,,189300831,1,Product used for unknown indication
18930086,189300861,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005982,BAUSCH AND LOMB,,,,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189300861,DE,,,,,,,,,189300861,1,Product used for unknown indication
18930094,189300941,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005970,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189300941,OT,,,,,,,,,189300941,1,Bipolar disorder
18930096,189300961,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005987,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189300961,OT,,,,,,,,,189300961,1,Bipolar disorder
18930097,189300971,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005985,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189300971,OT,,,,,,,,,189300971,1,Bipolar disorder
18930098,189300981,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005991,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189300981,OT,,,,,,,,,189300981,1,Bipolar disorder
18930101,189301011,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006009,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189301011,OT,,,,,,,,,189301011,1,Bipolar disorder
18930107,189301072,2,F,,20210216,20210223,20210303,EXP,,CA-BAUSCH-BL-2021-006006,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210303,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189301072,OT,,,,,,,,,189301072,1,Bipolar disorder
18930111,189301111,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005992,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189301111,OT,,,,,,,,,189301111,1,Bipolar disorder
18930112,189301121,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006003,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189301121,OT,,,,,,,,,189301121,1,Bipolar disorder
18930113,189301131,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005998,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189301131,OT,,,,,,,,,189301131,1,Bipolar disorder
18930116,189301161,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006024,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189301161,OT,,,,,,,,,189301161,1,Bipolar disorder
18930120,189301201,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006015,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189301201,OT,,,,,,,,,189301201,1,Product used for unknown indication
18930131,189301311,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006061,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189301311,OT,,,,,,,,,189301311,1,Bipolar disorder
18930133,189301331,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006059,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189301331,OT,,,,,,,,,189301331,1,Bipolar disorder
18930147,189301471,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006073,BAUSCH AND LOMB,,,,,M,Y,,,20210223,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction,189301471,OT,,,,,,,,,189301471,1,Product used for unknown indication
18930149,189301491,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006082,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189301491,DE,,,,,,,,,189301491,1,Bipolar disorder
18930155,189301551,1,I,,20210209,20210223,20210223,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013645,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities,189301551,OT,,,,,,,,,189301551,1,HIV infection
18930168,189301681,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006106,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189301681,OT,,,,,,,,,189301681,1,Bipolar disorder
18930884,189308841,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006101,BAUSCH AND LOMB,,,,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189308841,DE,,,,,,,,,189308841,1,Product used for unknown indication
18931021,189310211,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005965,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189310211,OT,,,,,,,,,189310211,1,Bipolar disorder
18931023,189310231,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-005974,BAUSCH AND LOMB,,44,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,189310231,HO,,,,,,,,,189310231,1,Depression
18931024,189310241,1,I,,20210216,20210223,20210223,EXP,,CA-BAUSCH-BL-2021-006051,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210223,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189310241,OT,,,,,,,,,189310241,1,Product used for unknown indication
18932084,189320841,1,I,,20210217,20210224,20210224,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-084598",BOEHRINGER INGELHEIM,,52,YR,A,M,Y,,,20210224,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,189320841,OT,,,,,,,,,189320841,1,HIV infection
18935926,189359261,1,I,,20210217,20210224,20210224,EXP,,CA-ROCHE-2772432,ROCHE,,,,,M,Y,,,20210224,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction,189359261,OT,,,,,,,,,189359261,1,Product used for unknown indication
18943295,189432951,1,I,,20210216,20210226,20210226,PER,,US-TEVA-2021-US-1884777,TEVA,,,,,F,Y,,,20210226,,HP,US,US,EFAVIRENZ W/EMTRICITABINE W/TENOFOVIR TEVA,Headache,,,,,,,,,,,189432951,1,Malignant connective tissue neoplasm
18947791,189477911,1,I,,20210216,20210226,20210226,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053477,VIIV,,,,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189477911,OT,,,,,,,,,189477911,1,Product used for unknown indication
18947792,189477921,1,I,,20210216,20210226,20210226,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053838,VIIV,,,,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189477921,DE,,,,,,,,,189477921,1,Product used for unknown indication
18947793,189477931,1,I,,20210216,20210226,20210226,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053518,VIIV,,54,YR,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189477931,OT,,,,,,,,,189477931,1,Bipolar disorder
18947794,189477941,1,I,,20210216,20210226,20210226,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053422,VIIV,,,,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189477941,DE,,,,,,,,,189477941,1,Product used for unknown indication
18947796,189477961,1,I,,20210216,20210226,20210226,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053629,VIIV,,54,YR,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189477961,OT,,,,,,,,,189477961,1,Bipolar disorder
18947852,189478521,1,I,,20210216,20210226,20210226,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053629,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189478521,OT,,,,,,,,,189478521,1,Bipolar disorder
18947855,189478551,1,I,,20210216,20210226,20210226,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053422,GLAXOSMITHKLINE,,,,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189478551,DE,,,,,,,,,189478551,1,Product used for unknown indication
18947859,189478591,1,I,,20210216,20210226,20210226,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053838,GLAXOSMITHKLINE,,,,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189478591,DE,,,,,,,,,189478591,1,Product used for unknown indication
18947860,189478601,1,I,,20210216,20210226,20210226,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053471,GLAXOSMITHKLINE,,44,YR,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychotic disorder;Suicidal ideation;Tearfulness,189478601,HO,,,,,,,,,189478601,1,Depression
18947865,189478651,1,I,,20210216,20210226,20210226,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053477,GLAXOSMITHKLINE,,,,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189478651,OT,,,,,,,,,189478651,1,Product used for unknown indication
18947871,189478711,1,I,,20210216,20210226,20210226,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053518,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210226,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189478711,OT,,,,,,,,,189478711,1,Bipolar disorder
18954096,189540961,1,I,,20210216,20210301,20210301,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053812,VIIV,,54,YR,,M,Y,,,20210301,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189540961,OT,,,,,,,,,189540961,1,Product used for unknown indication
18954097,189540971,1,I,,20210216,20210301,20210301,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053762,VIIV,,54,YR,,M,Y,,,20210301,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189540971,OT,,,,,,,,,189540971,1,Bipolar disorder
18954098,189540981,1,I,,20210216,20210301,20210301,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053527,VIIV,,54,YR,,M,Y,,,20210301,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189540981,OT,,,,,,,,,189540981,1,Bipolar disorder
18954100,189541001,1,I,,20210216,20210301,20210301,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053499,VIIV,,54,YR,,M,Y,,,20210301,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189541001,OT,,,,,,,,,189541001,1,Product used for unknown indication
18954101,189541011,1,I,,20210216,20210301,20210301,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053625,VIIV,,,,,M,Y,,,20210301,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction,189541011,OT,,,,,,,,,189541011,1,Product used for unknown indication
18954102,189541021,1,I,,20210216,20210301,20210301,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053470,VIIV,,54,YR,,M,Y,,,20210301,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189541021,OT,,,,,,,,,189541021,1,Bipolar disorder
18954111,189541111,1,I,,20210216,20210301,20210301,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053499,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210301,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189541111,OT,,,,,,,,,189541111,1,Product used for unknown indication
18954113,189541131,1,I,,20210216,20210301,20210301,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053625,GLAXOSMITHKLINE,,,,,M,Y,,,20210301,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction,189541131,OT,,,,,,,,,189541131,1,Product used for unknown indication
18954120,189541201,1,I,,20210216,20210301,20210301,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053527,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210301,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189541201,OT,,,,,,,,,189541201,1,Bipolar disorder
18954143,189541431,1,I,,20210216,20210301,20210301,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053812,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210301,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189541431,OT,,,,,,,,,189541431,1,Product used for unknown indication
18954146,189541461,1,I,,20210216,20210301,20210301,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053470,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210301,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189541461,OT,,,,,,,,,189541461,1,Bipolar disorder
18954149,189541491,1,I,,20210216,20210301,20210301,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053762,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210301,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189541491,OT,,,,,,,,,189541491,1,Bipolar disorder
18954763,189547631,1,I,,20210216,20210301,20210301,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053575,VIIV,,54,YR,,M,Y,,,20210301,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189547631,OT,,,,,,,,,189547631,1,Bipolar disorder
18954764,189547641,1,I,,20210216,20210301,20210301,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053575,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210301,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189547641,OT,,,,,,,,,189547641,1,Bipolar disorder
18958016,189580161,1,I,,20210216,20210302,20210302,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053430,VIIV,,54,YR,,M,Y,,,20210302,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189580161,OT,,,,,,,,,189580161,1,Bipolar disorder
18958132,189581321,1,I,,20210216,20210302,20210302,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053430,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210302,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189581321,OT,,,,,,,,,189581321,1,Bipolar disorder
18958251,189582511,1,I,,20210223,20210302,20210302,EXP,,US-MYLANLABS-2021M1012499,MYLAN,,,,A,M,Y,,,20210302,,HP,US,US,EFAVIRENZ.,Drug ineffective,189582511,OT,,,,,,,,,189582511,1,Hodgkin's disease
18958371,189583711,1,I,20181214,20210223,20210302,20210302,EXP,,CZ-VIIV HEALTHCARE LIMITED-CZ2021EME053964,VIIV,,53,YR,,M,Y,,,20210302,,CN,CZ,CZ,EFAVIRENZ.,Drug ineffective;Dysuria;HIV infection;Immunodeficiency;Kaposi's sarcoma;Laboratory test abnormal;Lymphoedema;Multiple-drug resistance;Neoplasm progression;Pancytopenia;Pyrexia;Skin lesion;Toxicity to various agents;Urinary tract infection;Virologic failure,189583711,OT,,,189583711,1,199502,19990322,,,189583711,1,HIV infection
18958395,189583951,1,I,20181214,20210223,20210302,20210302,EXP,,CZ-GLAXOSMITHKLINE-CZ2021EME053964,GLAXOSMITHKLINE,,53,YR,,M,Y,,,20210302,,CN,CZ,CZ,EFAVIRENZ.,Drug ineffective;Dysuria;HIV infection;Immunodeficiency;Kaposi's sarcoma;Laboratory test abnormal;Lymphoedema;Multiple-drug resistance;Neoplasm progression;Pancytopenia;Pyrexia;Skin lesion;Toxicity to various agents;Urinary tract infection;Virologic failure,189583951,OT,,,189583951,1,199502,19990322,,,189583951,1,HIV infection
18958429,189584291,1,I,,20210216,20210302,20210302,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053531,VIIV,,54,YR,,M,Y,,,20210302,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189584291,OT,,,,,,,,,189584291,1,Bipolar disorder
18958430,189584301,1,I,,20210216,20210302,20210302,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053512,VIIV,,54,YR,,M,Y,,,20210302,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189584301,OT,,,,,,,,,189584301,1,Bipolar disorder
18958433,189584331,1,I,,20210216,20210302,20210302,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053512,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210302,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189584331,OT,,,,,,,,,189584331,1,Bipolar disorder
18958434,189584341,1,I,,20210216,20210302,20210302,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053531,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210302,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189584341,OT,,,,,,,,,189584341,1,Bipolar disorder
18959101,189591011,1,I,,20210226,20210302,20210302,EXP,,NVSC2021ZA045753,NOVARTIS,,45,YR,,F,Y,,,20210302,,HP,ZA,ZA,EFAVIRENZ.,Acute kidney injury;Drug-induced liver injury,189591011,OT,,,,,,,,,189591011,1,Product used for unknown indication
18959387,189593871,1,I,,20210216,20210302,20210302,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053576,VIIV,,54,YR,,M,Y,,,20210302,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189593871,OT,,,,,,,,,189593871,1,Bipolar disorder
18959400,189594001,1,I,,20210216,20210302,20210302,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053576,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210302,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189594001,OT,,,,,,,,,189594001,1,Bipolar disorder
18962597,189625971,1,I,,20210216,20210303,20210303,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053501,VIIV,,54,YR,,M,Y,,,20210303,,CN,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189625971,OT,,,,,,,,,189625971,1,Bipolar disorder
18962600,189626002,2,F,,20210216,20210303,20210316,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053494,VIIV,,54,YR,,M,Y,,,20210316,,CN,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189626002,OT,,,,,,,,,189626002,1,Bipolar disorder
18962611,189626112,2,F,,20210216,20210303,20210316,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053494,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210316,,CN,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189626112,OT,,,,,,,,,189626112,1,Bipolar disorder
18962619,189626191,1,I,,20210216,20210303,20210303,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053501,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210303,,CN,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189626191,OT,,,,,,,,,189626191,1,Bipolar disorder
18963107,189631071,1,I,,20210225,20210303,20210303,EXP,,ZA-MYLANLABS-2021M1013354,MYLAN,,45,YR,,F,Y,,,20210303,,HP,ZA,ZA,EFAVIRENZ.,Acute kidney injury;Drug-induced liver injury;Mixed liver injury,189631071,OT,,,,,,,,,189631071,1,HIV infection
18965581,189655811,1,I,2020,20210218,20210304,20210304,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-02543,LUPIN,,31,YR,,M,Y,,,20210304,,HP,IT,IT,EFAVIRENZ.,Off label use,189655811,OT,,,189655811,1,2020,2020,,,189655811,1,COVID-19
18965775,189657751,1,I,,20210216,20210303,20210303,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053649,VIIV,,54,YR,,M,Y,,,20210303,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189657751,OT,,,,,,,,,189657751,1,Bipolar disorder
18965890,189658901,1,I,,20210216,20210303,20210303,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053649,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210303,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189658901,OT,,,,,,,,,189658901,1,Bipolar disorder
18965896,189658961,1,I,,20210216,20210303,20210303,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK054509,GLAXOSMITHKLINE,,44,YR,,M,Y,,,20210303,,CN,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,189658961,HO,,,,,,,,,189658961,1,Depression
18968421,189684211,1,I,,20210225,20210304,20210304,EXP,,ZA-MYLANLABS-2021M1013396,MYLAN,,32,YR,,F,Y,,,20210304,,HP,ZA,ZA,EFAVIRENZ.,Cholestatic liver injury;Drug-induced liver injury,189684211,OT,,,,,,,,,189684211,1,HIV infection
18971386,189713861,1,I,,20210222,20210304,20210304,EXP,,DE-AUROBINDO-AUR-APL-2021-008585,AUROBINDO,,57,YR,,M,Y,,,20210305,,CN,DE,DE,EFAVIRENZ.,Drug resistance,189713861,OT,,,,,,,,,189713861,1,HIV infection
18972408,189724081,1,I,,20210302,20210305,20210305,EXP,,CA-ROCHE-2782290,ROCHE,,54,YR,,M,Y,,,20210305,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189724081,OT,,,,,,,,,189724081,1,HIV infection
18972424,189724241,1,I,,20210304,20210305,20210305,EXP,,CA-ROCHE-2783380,ROCHE,,,,,M,Y,,,20210305,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189724241,DE,,,,,,,,,189724241,1,Product used for unknown indication
18978639,189786391,1,I,,20210303,20210308,20210308,EXP,,CA-ROCHE-2782616,ROCHE,,54,YR,,M,Y,,,20210308,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189786391,OT,,,,,,,,,189786391,1,Bipolar disorder
18978708,189787081,1,I,,20210222,20210308,20210308,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-019282,BRISTOL MYERS SQUIBB,,,,N,M,Y,,,20210308,,HP,FR,FR,EFAVIRENZ.,Foetal exposure during pregnancy;Polycystic liver disease;Sickle cell disease;Spleen malformation,189787081,CA,,,189787081,1,20060426,20061018,,,189787081,1,Product used for unknown indication
18979513,189795131,1,I,,20210304,20210308,20210308,EXP,,CA-ROCHE-2783598,ROCHE,,54,YR,,M,Y,,,20210308,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189795131,OT,,,,,,,,,189795131,1,Bipolar disorder
18979711,189797113,3,F,,20210319,20210308,20210324,EXP,,KZ-AUROBINDO-AUR-APL-2021-009821,AUROBINDO,,,,A,M,Y,,,20210324,,HP,KZ,KZ,Efavirenz+Emtricitabine+Tenofovir,Headache;Migraine;Muscle tone disorder;Neuromyopathy;Product use in unapproved indication;Sleep disorder,189797113,OT,,,,,,,,,189797113,1,Neuralgia
18980892,189808921,1,I,20181214,20210304,20210308,20210308,EXP,,CZ-ABBVIE-21K-217-3801302-00,ABBVIE,,53,YR,,M,Y,,,20210308,,CN,CZ,CZ,EFAVIRENZ.,Drug ineffective;Dysuria;HIV infection;Immunodeficiency;Kaposi's sarcoma;Laboratory test abnormal;Lymphoedema;Multiple-drug resistance;Neoplasm progression;Pancytopenia;Skin lesion;Toxicity to various agents;Urinary tract infection;Virologic failure,189808921,OT,,,189808921,2,20000912,20061016,,,189808921,1,HIV infection
18981005,189810051,1,I,,20210304,20210308,20210308,EXP,,CA-ROCHE-2783916,ROCHE,,54,YR,,M,Y,,,20210308,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189810051,OT,,,,,,,,,189810051,1,Bipolar disorder
18981006,189810061,1,I,,20210304,20210308,20210308,EXP,,CA-ROCHE-2783433,ROCHE,,,,,M,Y,,,20210308,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189810061,DE,,,,,,,,,189810061,1,Product used for unknown indication
18981020,189810201,1,I,,20210304,20210308,20210308,EXP,,CA-ROCHE-2784213,ROCHE,,54,YR,,M,Y,,,20210308,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189810201,OT,,,,,,,,,189810201,1,Bipolar disorder
18981312,189813121,1,I,,20210304,20210308,20210308,EXP,,CA-ROCHE-2783920,ROCHE,,54,YR,,M,Y,,,20210308,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189813121,OT,,,,,,,,,189813121,1,Bipolar disorder
18981519,189815191,1,I,,20210303,20210308,20210308,EXP,,CA-ROCHE-2783000,ROCHE,,54,YR,,M,Y,,,20210308,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189815191,OT,,,,,,,,,189815191,1,Bipolar disorder
18983236,189832361,1,I,,20210228,20210308,20210308,EXP,,CA-ASTRAZENECA-2021A096702,ASTRAZENECA,,,,,M,Y,,,20210308,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189832361,OT,,,,,,,,,189832361,1,Product used for unknown indication
18983660,189836601,1,I,,20210223,20210309,20210309,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-018693,BRISTOL MYERS SQUIBB,,,,N,M,Y,,,20210309,,HP,FR,FR,EFAVIRENZ.,Foetal exposure during pregnancy;Hepatic cyst;Sickle cell disease;Splenomegaly,189836601,CA,,,189836601,1,20060426,20061018,,,189836601,1,Product used for unknown indication
18984081,189840811,1,I,,20210304,20210309,20210309,EXP,,CA-ROCHE-2783465,ROCHE,,54,YR,,F,Y,,,20210309,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189840811,OT,,,,,,,,,189840811,1,Bipolar disorder
18984371,189843711,1,I,,20210304,20210308,20210308,EXP,,CA-ROCHE-2783531,ROCHE,,,,,M,Y,,,20210308,,HP,CA,CA,EFAVIRENZ.,Depression;Drug interaction,189843711,OT,,,,,,,,,189843711,1,Product used for unknown indication
18985241,189852411,1,I,,20210304,20210309,20210309,EXP,,CA-ROCHE-2783515,ROCHE,,54,YR,,M,Y,,,20210309,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189852411,DE,,,,,,,,,189852411,1,Bipolar disorder
18989016,189890161,1,I,,20210224,20210309,20210309,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085635",BOEHRINGER INGELHEIM,,57,YR,A,M,Y,,,20210309,,MD,DE,DE,EFAVIRENZ.,Drug resistance,189890161,OT,,,,,,,,,189890161,1,HIV infection
18990840,189908401,1,I,,20210304,20210310,20210310,EXP,,CA-ROCHE-2784455,ROCHE,,,,,M,Y,,,20210310,,HP,CA,CA,EFAVIRENZ.,Depression;Drug interaction,189908401,OT,,,,,,,,,189908401,1,Product used for unknown indication
18994764,189947641,1,I,201901,20210302,20210310,20210310,EXP,,US-GILEAD-2021-0519571,GILEAD,,59,YR,A,M,Y,,,20210310,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Bedridden;Coronary artery surgery;Depression;Gait disturbance;Underweight,189947641,OT,,,189947641,1,199001,,,,189947641,1,HIV infection
18996132,189961321,1,I,,20210225,20210311,20210311,PER,,ZA-LUPIN PHARMACEUTICALS INC.-2021-02964,LUPIN,,45,YR,,F,Y,,,20210311,,HP,ZA,ZA,EFAVIRENZ.,Acute kidney injury;Drug-induced liver injury;Mixed liver injury,189961321,OT,,,,,,,,,189961321,1,Product used for unknown indication
18996625,189966251,1,I,,20210304,20210311,20210311,EXP,,CA-ROCHE-2783830,ROCHE,,54,YR,,M,Y,,,20210311,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,189966251,OT,,,,,,,,,189966251,1,Bipolar disorder
18997529,189975291,1,I,,20210303,20210311,20210311,EXP,,US-MYLANLABS-2021M1014513,MYLAN,"HANDOKO RC, CHAN P, JAGODZINSKI L, PINYAKORN S, PHANUPHAK N, SACDALAN C, ET AL. MINIMAL INCIDENCE OF CSF ESCAPE AFTER INITIATION OF ART IN ACUTE HIV INFECTION. TOP?ANTIVIR?MED 2019?27 (SUPPL. 1):163S?164S ABSTR. 450.",,,,M,Y,,,20210311,,HP,US,US,EFAVIRENZ/LAMIVUDINE/TENOFOVIR,Treatment failure,189975291,OT,,,,,,,,,189975291,1,Antiretroviral therapy
18997716,189977161,1,I,,20210304,20210311,20210311,EXP,,CA-ROCHE-2783370,ROCHE,,44,YR,,M,Y,,,20210311,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,189977161,HO,,,,,,,,,189977161,1,Depression
18997747,189977471,1,I,,20210304,20210311,20210311,EXP,,CA-ROCHE-2783410,ROCHE,,44,YR,,M,Y,,,20210311,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychotic disorder;Suicidal ideation;Tearfulness,189977471,HO,,,,,,,,,189977471,1,Depression
18997772,189977721,1,I,,20210304,20210311,20210311,EXP,,CA-ROCHE-2783607,ROCHE,,54,YR,,M,Y,,,20210311,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189977721,OT,,,,,,,,,189977721,1,Bipolar disorder
18998051,189980511,1,I,,20210301,20210311,20210311,EXP,,US-TEVA-2021-US-1887803,TEVA,"HUGHES MS, PIETROPAOLO M, VASUDEVAN MM, MARCELLI M, NGUYEN H. CHECKING THE CHECKPOINT INHIBITORS: A CASE OF AUTOIMMUNE DIABETES AFTER PD?1 INHIBITION IN A PATIENT WITH HIV. J?ENDOCR?SOC 2020?4(12):1?7.",,,A,M,Y,,,20210311,,MD,US,US,EFAVIRENZ.,Autoimmune disorder;Diabetes mellitus;Drug ineffective,189980511,OT,,,,,,,,,189980511,1,Hodgkin's disease
18999142,189991421,1,I,,20210308,20210311,20210311,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-023102,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210311,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Intentional product use issue,189991421,OT,,,,,,,,,189991421,1,Product used for unknown indication
19000469,190004691,1,I,20181214,20210308,20210312,20210312,EXP,,CZ-JNJFOC-20210312901,JOHNSON AND JOHNSON,,53,YR,A,M,Y,,,20210312,,MD,CZ,CZ,EFAVIRENZ.,Drug ineffective;Dysuria;HIV infection;Immunodeficiency;Kaposi's sarcoma;Laboratory test abnormal;Lymphoedema;Multiple-drug resistance;Neoplasm progression;Pancytopenia;Pyrexia;Skin lesion;Toxicity to various agents;Urinary tract infection;Virologic failure,190004691,OT,,,190004691,1,20170214,19990322,,,190004691,1,HIV infection
19000578,190005781,1,I,,20210308,20210311,20210311,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-023147,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210311,,CN,US,US,SUSTIVA,Drug screen positive,,,,,,,,,,,190005781,1,Product used for unknown indication
19002827,190028271,1,I,,20210224,20210312,20210312,EXP,,NVSC2021DE043726,NOVARTIS,,57,YR,,M,Y,,,20210312,,HP,DE,DE,EFAVIRENZ.,Drug resistance,190028271,OT,,,,,,,,,190028271,1,HIV infection
19004847,190048471,1,I,,20210308,20210312,20210312,EXP,,PH-GILEAD-2021-0520575,GILEAD,"DITAN I, ANDAL VM, PAGALING G, IGNACIO KH, DIMAL NP, ROXAS AJ. CRYPTOCOCCAL IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (C?IRIS) PRESENTING AS ACUTE CEREBELLITIS: A CASE REPORT AND REVIEW OF LITERATURE. UNK. 2020?101:UNK. DOI:10.1016/J.IJID.2020.09.462",30,YR,A,M,Y,,,20210312,,HP,PH,PH,EFAVIRENZ.,Immune reconstitution inflammatory syndrome,190048471,HO,,,,,,,,,190048471,1,HIV infection
19005353,190053531,1,I,,20210303,20210312,20210312,PER,,ZA-LUPIN PHARMACEUTICALS INC.-2021-03098,LUPIN,,,,A,F,Y,,,20210313,,HP,US,ZA,EFAVIRENZ.,Drug interaction,,,,,,,,,,,190053531,1,Tuberculosis
19005725,190057251,1,I,,20210303,20210314,20210314,EXP,,CA-JNJFOC-20210311775,JOHNSON AND JOHNSON,,44,YR,A,M,Y,,,20210314,,HP,CA,CA,SUSTIVA,Abdominal pain;Anxiety;Constipation;Depression;Depression suicidal;Depressive symptom;Drug interaction;Gastric infection;Muscle rigidity;Pain;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Rebound effect;Retching;Salivary hypersecretion;Sedation;Suicidal ideation;Tearfulness,190057251,HO,,,,,,,,,190057251,1,Depression
19011311,190113111,1,I,,20210309,20210315,20210315,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-023929,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210315,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction,190113111,HO,,,,,,,,,190113111,1,Product used for unknown indication
19012380,190123801,1,I,20180403,20180427,20210315,20210315,EXP,,DE-TAKEDA-DE201816353,TAKEDA,,46,YR,,M,Y,105,KG,20210315,,MD,DE,DE,EFAVIRENZ.,Abdominal infection;Gastric ulcer;Hepatic cirrhosis;Hepatic neoplasm;Varices oesophageal,190123801,HO,,,190123801,1,20090901,20120215,,,190123801,1,Prophylaxis
19012996,190129961,1,I,20200127,20210309,20210315,20210315,EXP,,UG-ORGANON-O2103UGA001729,ORGANON,,,,,F,Y,,,20210315,,CN,UG,UG,EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE,Drug interaction;Pregnancy with implant contraceptive;Unintended pregnancy,190129961,OT,,,190129961,1,20190403,,,,190129961,2,Antiretroviral therapy
19013794,190137941,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889833,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190137941,OT,,,,,,,,,190137941,1,HIV infection
19013877,190138771,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889881,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,190138771,OT,,,,,,,,,190138771,1,HIV infection
19014954,190149541,1,I,20181214,20210308,20210316,20210316,EXP,,"CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-088636",BOEHRINGER INGELHEIM,,53,YR,A,M,Y,,,20210316,,CN,CZ,CZ,EFAVIRENZ.,Drug ineffective;Dysuria;HIV infection;Immunodeficiency;Kaposi's sarcoma;Laboratory test abnormal;Lymphoedema;Multiple-drug resistance;Neoplasm progression;Pancytopenia;Pyrexia;Skin lesion;Toxicity to various agents;Urinary tract infection;Virologic failure,190149541,OT,,,190149541,10,20050808,20061016,,,190149541,1,HIV infection
19015877,190158771,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889773,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190158771,OT,,,,,,,,,190158771,1,Product used for unknown indication
19015919,190159191,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889800,TEVA,,,,,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190159191,HO,,,,,,,,,190159191,1,Product used for unknown indication
19016146,190161461,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889897,TEVA,,,,,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190161461,DE,,,,,,,,,190161461,1,Product used for unknown indication
19016203,190162031,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889879,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190162031,OT,,,,,,,,,190162031,1,HIV infection
19017605,190176051,1,I,,20210311,20210317,20210317,EXP,,CA-ROCHE-2789247,ROCHE,,54,YR,,M,Y,,,20210317,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190176051,OT,,,,,,,,,190176051,1,HIV infection
19019101,190191011,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889860,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,190191011,OT,,,,,,,,,190191011,1,HIV infection
19019102,190191021,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1890042,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191021,OT,,,,,,,,,190191021,1,Product used for unknown indication
19019103,190191031,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1890017,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191031,OT,,,,,,,,,190191031,1,HIV infection
19019104,190191041,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889535,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,190191041,OT,,,,,,,,,190191041,1,HIV infection
19019106,190191061,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1890025,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,190191061,OT,,,,,,,,,190191061,1,HIV infection
19019108,190191081,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889831,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,190191081,OT,,,,,,,,,190191081,1,HIV infection
19019110,190191101,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1890032,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,190191101,OT,,,,,,,,,190191101,1,HIV infection
19019120,190191201,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889840,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191201,OT,,,,,,,,,190191201,1,HIV infection
19019122,190191221,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889900,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191221,OT,,,,,,,,,190191221,1,HIV infection
19019124,190191241,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889532,TEVA,,,,,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191241,DE,,,,,,,,,190191241,1,Product used for unknown indication
19019126,190191261,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889830,TEVA,,,,,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191261,DE,,,,,,,,,190191261,1,Product used for unknown indication
19019133,190191331,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889880,TEVA,,,,,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191331,HO,,,,,,,,,190191331,1,Product used for unknown indication
19019136,190191361,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889901,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191361,OT,,,,,,,,,190191361,1,HIV infection
19019137,190191371,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1890035,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191371,OT,,,,,,,,,190191371,1,HIV infection
19019139,190191391,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889814,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191391,OT,,,,,,,,,190191391,1,HIV infection
19019142,190191421,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889898,TEVA,,,,,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191421,DE,,,,,,,,,190191421,1,Product used for unknown indication
19019143,190191431,1,I,,20210308,20210316,20210316,EXP,,CA-TEVA-2021-CA-1889824,TEVA,,54,YR,A,M,Y,,,20210316,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190191431,OT,,,,,,,,,190191431,1,Bipolar disorder
19022348,190223482,2,F,20210126,20210316,20210317,20210322,EXP,,UG-ORGANON-O2103UGA002009,ORGANON,,,,,F,Y,,,20210322,,CN,UG,UG,EFAVIRENZ/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE,Potentiating drug interaction;Pregnancy with implant contraceptive;Unintended pregnancy,190223482,OT,,,190223482,1,20190403,,,,190223482,1,Contraception
19022359,190223591,1,I,,20210303,20210318,20210318,EXP,,DE-009507513-2103DEU001244,MERCK,,57,YR,,M,Y,,,20210318,,CN,DE,DE,EFAVIRENZ.,Drug resistance,190223591,OT,,,,,,,,,190223591,1,HIV infection
19022399,190223991,1,I,,20210311,20210317,20210317,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2021APC060859,VIIV,,41,YR,,M,Y,,,20210317,,MD,CN,CN,EFAVIRENZ.,Abdominal pain;Abdominal pain lower;Acute kidney injury;Anuria;CD4 lymphocytes decreased;Death;Gastrointestinal oedema;Pancreatitis acute,190223991,HO,,,,,,,,,190223991,1,HIV infection
19022401,190224011,1,I,,20210311,20210317,20210317,EXP,,CN-GLAXOSMITHKLINE-CN2021APC060859,GLAXOSMITHKLINE,,41,YR,,M,Y,,,20210317,,MD,CN,CN,EFAVIRENZ.,Abdominal pain;Abdominal pain lower;Acute kidney injury;Anuria;CD4 lymphocytes decreased;Death;Gastrointestinal oedema;Pancreatitis acute,190224011,HO,,,,,,,,,190224011,1,HIV infection
19022439,190224391,1,I,20181214,20210308,20210317,20210317,EXP,,CZ-FRESENIUS KABI-FK202102518,FRESENIUS KABI,,53,YR,,M,Y,,,20210317,,HP,NL,CZ,EFAVIRENZ.,Drug ineffective;Dysuria;HIV infection;Immunodeficiency;Kaposi's sarcoma;Laboratory test abnormal;Lymphoedema;Multiple-drug resistance;Neoplasm progression;Pancytopenia;Pyrexia;Skin lesion;Toxicity to various agents;Urinary tract infection;Virologic failure,190224391,OT,,,190224391,1,2021,19990322,,,190224391,1,Kaposi's sarcoma
19024102,190241021,1,I,,20210304,20210318,20210318,EXP,,DE-35507-2021-03271,LUPIN,,57,YR,,M,Y,,,20210318,,CN,NL,DE,EFAVIRENZ.,Drug resistance,190241021,OT,,,,,,,,,190241021,1,HIV infection
19025153,190251531,1,I,,20210311,20210318,20210318,EXP,,CA-ROCHE-2789117,ROCHE,,,,,M,Y,,,20210318,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction,190251531,OT,,,,,,,,,190251531,1,Product used for unknown indication
19025352,190253521,1,I,,20210311,20210318,20210318,EXP,,CA-ROCHE-2789224,ROCHE,,,,,M,Y,,,20210318,,HP,CA,CA,EFAVIRENZ.,Depression;Drug interaction,190253521,OT,,,,,,,,,190253521,1,Product used for unknown indication
19025405,190254051,1,I,,20210311,20210318,20210318,EXP,,CA-ROCHE-2789274,ROCHE,,,,,M,Y,,,20210318,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190254051,OT,,,,,,,,,190254051,1,Product used for unknown indication
19029591,190295911,1,I,,20210308,20210319,20210319,EXP,,ZA-AUROBINDO-AUR-APL-2021-011257,AUROBINDO,,45,YR,,F,Y,,,20210319,,HP,ZA,ZA,EFAVIRENZ.,Acute kidney injury;Drug-induced liver injury,190295911,OT,,,,,,,,,190295911,1,Product used for unknown indication
19031184,190311841,1,I,,20210315,20210319,20210319,EXP,,FR-GILEAD-2021-0521755,GILEAD,"DE CASTRO N, MARCY O, CHAZALLON C, MESSOU E, EHOLIE S, N^TAKPE JB, BHATT N, KHOSA C, TIMANA MI, LAUREILLARD, CHAU GD, DOMERGUE A, VELOSO V, ESCADA R, WAGNER CS, DELAUGERRE C, ANGLARET, MOLINA JM. STANDARD DOSE RALTEGRAVIR OR EFAVIRENZ?BASED ANTIRETROVIRAL TREATMENT FOR PATIENTS CO?INFECTED WITH HIV AND TUBERCULOSIS (ANRS 12 300 REFLATE TB 2): AN OPEN?LABEL, NON?INFERIORITY, RANDOMISED, PHASE 3 TRIAL. LANCET INFECT DIS.. 2021?UNK:1?23. DOI:10.1016/S1473?3099(20)30869?0",,,A,,Y,,,20210319,,MD,FR,FR,EFAVIRENZ.,Immune reconstitution inflammatory syndrome associated tuberculosis,190311841,OT,,,,,,,,,190311841,1,HIV infection
19032425,190324251,1,I,,20210308,20210319,20210319,PER,,PK-LUPIN PHARMACEUTICALS INC.-2021-03297,LUPIN,,49,YR,,F,Y,,,20210319,,HP,PK,PK,EFAVIRENZ.,Drug ineffective,190324251,OT,,,190324251,2,2017,,,,190324251,1,HIV-associated neurocognitive disorder
19033823,190338231,1,I,20181214,20210309,20210319,20210319,EXP,,CZ-ROCHE-2786120,ROCHE,,53,YR,,M,Y,,,20210319,,MD,CZ,CZ,EFAVIRENZ.,Drug ineffective;Dysuria;HIV infection;Immunodeficiency;Kaposi's sarcoma;Laboratory test abnormal;Lymphoedema;Multiple-drug resistance;Neoplasm progression;Pancytopenia;Pyrexia;Skin lesion;Toxicity to various agents;Urinary tract infection;Virologic failure,190338231,OT,,,190338231,1,199502,19990322,,,190338231,1,HIV infection
19034484,190344841,1,I,,20210310,20210319,20210319,EXP,,CA-TEVA-2021-CA-1890105,TEVA,,54,YR,A,M,Y,,,20210319,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190344841,OT,,,,,,,,,190344841,1,HIV infection
19034557,190345571,1,I,20181214,20210311,20210319,20210319,EXP,,CZ-009507513-2103CZE003413,MERCK,,53,YR,,M,Y,,,20210319,,MD,CZ,CZ,EFAVIRENZ.,Drug ineffective;Dysuria;HIV infection;Immunodeficiency;Kaposi's sarcoma;Laboratory test abnormal;Lymphoedema;Multiple-drug resistance;Neoplasm progression;Pancytopenia;Pyrexia;Skin lesion;Toxicity to various agents;Urinary tract infection;Virologic failure,190345571,OT,,,190345571,5,199502,19990322,,,190345571,1,HIV infection
19039334,190393341,1,I,,20210309,20210322,20210322,EXP,,IN-GLAXOSMITHKLINE-IN2021GSK061250,GLAXOSMITHKLINE,,45,YR,,M,Y,,,20210322,,HP,IN,IN,EFAVIRENZ.,B-cell lymphoma;Drug ineffective;Mouth ulceration;Non-Hodgkin's lymphoma;Oral discomfort;Oral disorder;Oral pain;Pyrexia;Virologic failure;Weight decreased,190393341,OT,,,,,,,,,190393341,1,Antiretroviral therapy
19039343,190393431,1,I,,20210309,20210322,20210322,EXP,,IN-VIIV HEALTHCARE LIMITED-IN2021GSK061250,VIIV,,45,YR,,M,Y,,,20210322,,HP,IN,IN,EFAVIRENZ.,B-cell lymphoma;Drug ineffective;Mouth ulceration;Non-Hodgkin's lymphoma;Oral discomfort;Oral disorder;Oral pain;Pyrexia;Virologic failure;Weight decreased,190393431,OT,,,,,,,,,190393431,1,Antiretroviral therapy
19040462,190404621,1,I,,20210310,20210323,20210323,EXP,,IN-CIPLA LTD.-2021IN02132,CIPLA,,,,,,Y,,,20210323,,HP,IN,IN,EFAVIRENZ/LAMIVUDINE/TENOFOVIR,Treatment failure;Viral load increased,190404621,OT,,,,,,,,,190404621,1,Acquired immunodeficiency syndrome
19040806,190408061,1,I,,20210309,20210322,20210322,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-023855,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210322,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Off label use,190408061,OT,,,,,,,,,190408061,1,Product used for unknown indication
19040818,190408181,1,I,,20210308,20210322,20210322,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-023401,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210322,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,190408181,OT,,,,,,,,,190408181,1,HIV infection
19050666,190506661,1,I,,20210309,20210324,20210324,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-01250,HIKMA,"HUGHES M, PIETROPAOLO M, VASUDEVAN M, MARCELLI M, NGUYEN H. CHECKING THE CHECKPOINT INHIBITORS: A CASE OF AUTOIMMUNE DIABETES AFTER PD?1 INHIBITION IN A PATIENT WITH HIV. JOURNAL OF THE ENDOCRINE SOCIETY. 2020?4 (12):1?7. DOI:DOI:10.1210/JENDSO/BVAA150",48,YR,,M,Y,,,20210324,,,COUNTRY NOT SPECIFIED,US,EFAVIRENZ.,Blood glucose increased;Impaired fasting glucose,190506661,OT,,,,,,,,,190506661,1,Hodgkin's disease
19053681,190536811,1,I,,20210310,20210325,20210325,EXP,,DE-TEVA-2021-DE-1891494,TEVA,,57,YR,A,M,Y,,,20210325,,CN,DE,DE,EFAVIRENZ.,Drug resistance,190536811,OT,,,,,,,,,190536811,1,HIV infection
19057022,190570221,1,I,,20210315,20210324,20210324,PER,,US-TEVA-2021-US-1892436,TEVA,,,,,,Y,,,20210324,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE TEVA,Urticaria,,,,,,,,,,,,,
19059090,190590901,1,I,20181214,20210304,20210325,20210325,EXP,,CZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-022037,BRISTOL MYERS SQUIBB,,53,YR,,M,Y,,,20210325,,MD,CZ,CZ,EFAVIRENZ.,Drug ineffective;Dysuria;HIV infection;Immunodeficiency;Kaposi's sarcoma;Laboratory test abnormal;Lymphoedema;Malignant neoplasm progression;Multiple-drug resistance;Pancytopenia;Pyrexia;Skin lesion;Toxicity to various agents;Urinary tract infection;Virologic failure,190590901,OT,,,190590901,2,20000403,19990322,,,190590901,1,HIV infection
19059254,190592541,1,I,,20210223,20210326,20210326,PER,,US-STRIDES ARCOLAB LIMITED-2021SP002599,STRIDES,"HUGHES MS, PIETROPAOLO M, VASUDEVAN MM, MARCELLI M, NGUYEN H.. CHECKING THE CHECKPOINT INHIBITORS: A CASE OF AUTOIMMUNE DIABETES AFTER PD?1 INHIBITION IN A PATIENT WITH HIV. J?ENDOCR?SOC. 2020?4(12):1?7",48,YR,,M,Y,,,20210326,,HP,US,US,EFAVIRENZ.,Drug ineffective;Off label use,190592541,OT,,,,,,,,,190592541,1,Hodgkin's disease
19063172,190631722,2,F,2016,20210325,20210326,20210330,EXP,,US-MYLANLABS-2021M1017154,MYLAN,,52,YR,,M,Y,,,20210330,,LW,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Anhedonia;Arthralgia;Bone density decreased;Hip fracture;Multiple fractures;Osteoporosis;Pain;Renal injury;Skeletal injury;Spinal compression fracture,190631722,OT,,,190631722,1,20150126,20181204,,,190631722,1,HIV infection
19068707,190687071,1,I,,20210310,20210329,20210329,PER,,US-009507513-2103USA007474,MERCK,,64,YR,,M,Y,,,20210329,,MD,US,US,efavirenz (+) emtricitabine (+) tenofovir disoproxil fumarate,Drug ineffective,,,,,,,,,,,190687071,1,Neuroendocrine carcinoma of the skin
19069028,190690281,1,I,,20210321,20210329,20210329,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-028187,BRISTOL MYERS SQUIBB,,58,YR,,M,Y,,,20210329,,MD,GB,GB,EFAVIRENZ + EMTRICITABINE + TENOFOVIR [EFAVIRENZ;EMTRICITABINE;TENOFOVIR];EFAVIRENZ.,Nephropathy toxic,190690281,OT,,,,,,,,,190690281,1,HIV infection
19069125,190691251,1,I,,20210316,20210329,20210329,EXP,,RO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-026456,BRISTOL MYERS SQUIBB,,39,YR,,F,Y,,,20210329,,MD,RO,RO,EFAVIRENZ.,Dyslipidaemia;Lipodystrophy acquired,190691251,OT,,,,,,,,,190691251,1,HIV infection
19069695,190696951,1,I,,20210321,20210329,20210329,EXP,,CA-ASTRAZENECA-2021A182881,ASTRAZENECA,,54,YR,,M,Y,,,20210329,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190696951,OT,,,,,,,,,190696951,1,Product used for unknown indication
19073922,190739221,1,I,,20210315,20210330,20210330,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK069243,VIIV,,54,YR,,M,Y,,,20210330,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,190739221,OT,,,,,,,,,190739221,1,Product used for unknown indication
19073938,190739381,1,I,,20210315,20210330,20210330,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK069243,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210330,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,190739381,OT,,,,,,,,,190739381,1,Product used for unknown indication
19079414,190794141,1,I,20070106,20190124,20210331,20210331,EXP,FR-AFSSAPS-BX0700034,FR-VALIDUS PHARMACEUTICALS LLC-FR-2021VAL000383,VALIDUS,,47,YR,,M,Y,,,20210331,,HP,FR,FR,EFAVIRENZ MYLAN,Aphthous ulcer;Drug reaction with eosinophilia and systemic symptoms;Eosinophilia;Eyelid oedema;Face oedema;Hepatitis;Lip oedema;Oral disorder;Pruritus;Rash maculo-papular;Rash papular;Rash vesicular,190794141,HO,,,190794141,2,20061129,20070108,,,190794141,1,Product used for unknown indication
19079825,190798251,1,I,,20210324,20210331,20210331,EXP,,CA-009507513-2103CAN007454,MERCK,,,,,M,Y,,,20210331,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction,190798251,OT,,,,,,,,,190798251,1,Product used for unknown indication
3990923,399092311,11,F,20030725,20210126,20030828,20210207,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-12363941,BRISTOL MYERS SQUIBB,"BEGUINOT I, FRANCOZ B, BERNARD?CHABERT A, MOLIA A, BRODARD V, BERGER JL, ET AL. SECOND OBSERVATION OF A FULMINANT HEPATITIS IN A FEMALE PATIENT NOT COINFECTED, UNDER ANTIRETROVIRAL TRITHERAPY INCLUDING EFAVIRENZ. MEDICINE AND INFECTIOUS DISEASE. 2004?34(1):S148",43,YR,,F,Y,74,KG,20210207,,HP,FR,FR,SUSTIVA,Aggression;Ascites;Hepatic necrosis;Hepatitis A;Jaundice;Peritoneal haematoma;Somnolence;Vomiting,399092311,HO,,,399092311,1,20030412,20030728,,,399092311,1,HIV infection
7117171,711717115,15,F,,20210208,20090917,20210222,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-14780902,BRISTOL MYERS SQUIBB,"PFEFFER G, COTE HCF, MONTANER JS, LI CC, JITRATKOSOL M, MEZEI MM. OPHTHALMOPLEGIA AND PTOSIS: MITOCHONDRIAL TOXICITY IN PATIENTS RECEIVING HIV THERAPY. NEUROLOGY. 2009?73(1):71?2",52,YR,,M,Y,,,20210222,,MD,CA,CA,EFAVIRENZ.;SUSTIVA,Diplopia;Extraocular muscle paresis;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia;Progressive external ophthalmoplegia,711717115,OT,,,711717115,8,200802,,,,711717115,1,HIV infection
